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Summary 
 
The Skin is the largest organ in the mammalian body and serves as a barrier to protect 
the body from dehydration, mechanical trauma, and microbial invasion. In a healthy 
organism, the upper skin level - the epidermis regenerates constantly through the duration of 
life via continual proliferation, migration and differentiation.  
To date, skin replacements for patients with large burn injuries are generated with patients 
own keratinocytes, if possible. But the isolation, expansion in culture, and generation of the 
skin equivalent are time consuming. Decellularized cadaver skin is used to cover the wounds 
in the meantime. However, cadaver skin is rare and can cause an immune response.  
The application of induced pluripotent stem cells (iPSCs) in regenerative medicine and 
tissue engineering offers great possibilities. IPSCs display a nearly inexhaustible source of 
pluripotent cells, which can be differentiated into nearly every cell type of the mammalian 
organism. This enables to study differentiation processes during embryogenesis, especially 
in humans, which cannot be addressed in vivo.  
Furthermore, patient-specific iPSCs can be generated and used to establish patients-
specific skin cultures.  
The differentiation of iPSCs into keratinocytes is a critical process. In order to use these 
iPSC-derived keratinocytes for skin replacements a pure cell population is required. Existing 
protocols for the differentiation of pluripotent stem cells into keratinocytes have been 
improved during the last years. Nevertheless, these protocols do not lead to a pure 
population of iPSC-derived keratinocytes.  
The aim of this project was to find new regulators, which are involved in the differentiation 
of pluripotent cells into the epithelial lineage.  
Therefore I generated hiPSCs from fibroblasts of healthy donors and validated their 
pluripotent state by investigating the expression of pluripotency associated markers on RNA 
and protein level. Furthermore, I performed the termatoma assay, the most stringent test for 
pluripotency.  
The generated iPSCs were differentiated by using a published protocol for 30 day, by 
culturing them in a defined medium supplemented with BMP4 and retinoic acid. The 
generated keratinocytes were shown to express basal and suprabasal keratinocyte markers 
on RNA and protein level.  
In order to find new factors which are involved in the development of early epithelial cells, 
I adapted a high-throughput siRNA screen to the iPSC differentiation. This screen enabled 
the knock-down of nearly 800 kinases during the differentiation of iPSCs into an epithelial 
lineage.  
HIPK4 was one of the top fifty candidates, which resulted in enhanced expression of the 
embryonic epidermal marker keratin 18. In further investigations, I could show that HIPK4 
resulted not only in enhanced expression levels of keratin 18, but also the expression of 
other epithelial markers was increased.  
I could demonstrate that the knock-down of HIPK4 especially in the first few days has an 
enhancing effect on the differentiation and that this effect is only present in the presence of 
retinoic acid in the differentiation medium.  
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Zusammenfassung 
 
Die Haut ist das größte Organ der Säugetiere und fungiert als schützende Barriere, die 
den Organismus vor Austrocknung, mechanischen Verletzungen von außen und Infektion 
schützt. In einem gesunden Organismus regeneriert und erneuert sich die oberste 
Hautschicht - Epidermis kontinuierlich das ganze Leben lang. Die Erneuerung und 
Regeneration der Haut wird durch ununterbrochene Zellteilung, Migration und 
Differenzierung gewährleistet.  
Haut-transplantate für Patienten mit großflächigen Verbrennungen werden, wenn möglich, 
mit Patienten-eigenen Keratinozyten hergestellt. Allerdings ist die Generierung der Haut 
Äquivalente sehr zeitaufwendig und um die Wunde in der Wartezeit zu bedecken wird 
dezellularisierte Leichenhaut verwendet. Diese ist aber rar und kann zusätzlich eine 
Abstoßungsreaktion auslösen. 
Der Einsatz von induzierten pluripotenten Stammzellen (iPSCs) in der regenerativen 
Medizin und dem Tissue Engineering eröffnet viele Möglichkeiten. IPSCs stellen eine nahezu 
unversiegbare Quelle an pluripotenten Zellen dar, die in fast alle Zelltypen differenziert 
werden können. Das macht sie zu einem einzigartigen Modelsystem, das die Untersuchung 
von entwicklungsbiologischen Prozessen des menschlichen Körpers ermöglicht. 
Weiterhin können Patienten-spezifische iPSCs generiert werden und somit Patienten-
spezifische Hautäquivalente.  
Die Differenzierung von iPSCs zu Keratinozyten ist ein kompliziertes Verfahren. Um 
Keratinozyten für die Generierung von Hautäquivalenten zu verwenden müssen die 
Differenzierungen eine reine Population ohne andere Zelltypen herstellen. Protokolle wurden 
immer mehr verbessert, allerdings erzielen sie weiterhin keine reinen Populationen.  
Das Ziel dieser Arbeit war es neue Kandidaten zu finden, die eine Rolle während der 
Differenzierung von pluripotenten Zellen in die epitheliale Richtung spielen, zu finden.  
Dafür habe ich Fibroblasten von gesunden Donoren zu humane iPSCs reprogrammiert 
und ihren pluripotenten Status auf RNA und Proteinebene verifiziert. Außerdem habe ich den 
Teratom Assay durchgeführt, der kritischste Test um den pluripotenten Status zu verifizieren. 
Die reprogrammierten iPSCs wurden dann anhand eines publizierten Protokolls in 
Keratinozyten differenziert. Das Protokoll basierte auf der Verwendung eines definierten 
Mediums und der Zugabe von BMP4 und Retinsäure. Es wurde gezeigt, dass die generierten 
Keratinozyten basale und suprabasale Keratinozytenmarker auf RNA und Proteinebene 
exprimieren.  
Um neue Faktoren zu finden, die einen Einfluss auf die Differenzierung von pluripotenten 
Zellen zu frühen Epithelzellen haben, habe ich die Differenzierung im Hochdurchsatz siRNA 
Screening angepasst und etabliert. Dieser Screen ermöglicht durch die Transfektion mit 
siRNAs den knock-down von nahezu 800 Kinasen während der Differenzierung.  
HIKP4 war einer der Kandidaten der top Fünfzig, durch deren knock-down die Expression 
des embryonalen Epidermis Markers Keratin 18 erhöht wird. Zusätzliche Untersuchungen 
haben gezeigt, dass nicht nur die Expression von Keratin 18, sondern noch einiger weiterer 
epithelialer Marker erhöht war, wenn HIPK4 runterreguliert war. Weiterhin konnte ich zeigen, 
dass dieser Effekt zutrifft, wenn HIPK4 in den ersten 5 Tagen runterreguliert ist und das 
Medium Retinsäure enthält.  
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1 Introduction 
 
1.1 The human skin 
 
The surface of our body, the skin epidermis and its appendages, provides a barrier which 
protects us against external environmental insults, while keeping essential body fluids inside 
to prevent us from dehydration. Every day this barrier is exposed to ultraviolet radiation from 
the sun, mechanical trauma like scratches and wounds, and microbial invasion. The 
epidermis confronts these traumas through ongoing self-renewal. The process of self-
renewal is assured through continuous proliferation, differentiation and migration of the cells 
and must be carefully balanced to sustain a healthy homeostasis. The human skin epidermis 
is a tissue with a complex architecture. It is a stratified squamous epithelium consisting of 
several cell types, including keratinocytes, melanocytes and Langerhans cells. Keratinocytes 
are the most abundant cell type and appear in different differentiation stages. The epidermis 
is non-vascularized and receives its nutrients from the blood vessels of the underlying 
dermis. 
 
 
1.1.1 The skin´s architecture and homeostasis 
 
1.1.1.1 Generation and characterization of the different layers  
 
The skin epidermis is a self-renewing stratified epithelium maintained by the proliferation, 
migration and differentiation of keratinocytes. This process starts at the lowermost layer of 
the epidermis, the basal layer or stratum basale, where keratinocytes proliferate, detach from 
the underlying basement membrane and migrate upwards. The overlying layer is the stratum 
spinosum, or spinous layer. This layer is characterized by dense cell-cell connections, 
named desmosomes, and the expression of the first differentiation markers, including 
involucrin and transglutaminase 1. The cells of the next layer, the stratum granulosum (or 
granular layer) cells are rich in granules containing products to assemble various terminal 
keratinocyte structures. These cells are metabolically active until they reach the next layer, 
the stratum lucidum, the transition zone between living epidermal cells and dead cells. In this 
region organelles and nuclei are degraded. The uppermost layer, the stratum corneum, is 
occupied by dead flattened cells, which consist of a stabilized array of keratin filament 
covalently crosslinked to a cornified envelope. In the last step, the terminally differentiated 
corneocytes are shed from the surface, making room for subsequent terminally differentiated 
cells (Figure 1). 
The skin epidermis is a self-renewing tissue with a constant number of cells. This 
homeostasis is maintained by stem cells in the basal layer. It is still not clear whether all cells 
in the basal layer have stem cell potential or only a small fraction of cells maintains the stem 
cell equilibrium. Furthermore it remains unclear if these stem cells divide asymmetrically or 
symmetrically (the recent findings are further displayed in chapter “1.1.1.5 Stem cells of the 
interfollicular epidermis”). Basal cells are characterized by their expression of keratin 5 and 
14 (K5, K14; also named cytokeratin 5 and cytokeratin 14) (Banks-Schlegel, 1982; Moll et al., 
1982). Periodically, basal cells withdraw from the cell cycle, migrate from the basal to the 
spinous layer and begin to synthesize a new set of structural proteins and enzymes that are 
characteristic for cornification. These differentiating, migrating cells downregulate the 
expression of K5 and K14, while keratin 1 and 10 (K1, K10) expression is induced 
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(Candi et al., 2005). Only suprabasal keratins are able to form heterodimers that assemble 
into heteropolymers and intermediate filaments (Coulombe and Wong, 2004). 
In the upper stratum spinosum and the stratum granulosum, the cells exhibit keratohyalin 
granules, which contain profilaggrin - the precursor of the interfilament protein filaggrin 
(Matoltsy, 1975). In addition, a number of other structural proteins are synthesized, including 
involucrin, loricrin and small proline-rich proteins (SPRs), which are crosslinked by several 
transglutaminases to reinforce a cornified envelope beneath the plasma membrane. 
Transglutaminases (TGs) are enzymes that are essential for a correct cornified-envelope 
assembly, by catalyzing the generation of very stable isopeptide bonds between the 
structural proteins. In the skin epidermis TG1, TG3 and TG5 are involved in the formation of 
the cornified envelope (Candi et al., 2005; Simon and Green, 1988).  
The structural protein involucrin is highly α-helical and is crosslinked by TG1 to many 
other structural proteins and thereby contributes to the buildup of a scaffold to which further 
structural proteins become crosslinked (Rice and Green, 1977). An additional structural 
protein is loricrin which is the main component of the cornified envelope and constitutes 70-
85% of its protein mass. Mainly isopeptide bound loricrin-loricrin crosslinks are found in the 
cornified envelope, but smaller amounts of loricrin are also crosslinked to SPRs which 
function as cross-bridging proteins among loricrins (Candi et al., 1995). Even though the 
amount of loricrin and SRPs is always ~85%, the ratio of SPRs and loricrin varies from 1:100 
in thinner epidermal regions to about 1:1000 in thicker epidermal parts, including palm and 
sole epidermis (Candi et al., 1999). This shows that the flexibility, rigidity or toughness is 
strongly dependent on the amounts and proportion of crosslinked partners. Furthermore, 
loricrin crosslinked with SPRs is deposited on a scaffold of involucrin, cystatin A, elafin and 
desmosomal proteins (Takahashi et al., 1992), and in addition, it is also crosslinked to keratin 
and filaggrin. This demonstrates that the keratin intermediate filament complex of cornified 
epidermal cells is covalently bound to the cornified envelope (Steinert and Marekov, 1995). 
These various crosslinks of loricrin are strengthened by multiple TGs that are required for 
loricrin crosslinking in the epidermis. Before loricrin is crosslinked to the cornified envelope, it 
is intermixed with profilaggrin and deposited in the keratohyalin granules in the granular layer 
of the epidermis (Yoneda and Steinert, 1993).  
Profilaggrin is a large complex protein that contains 10 – 12 filaggrin units joined together 
which accumulates in the keratohyalin granules. Initially, it is highly phosphorylated, but 
becomes dephosphorylated and proteolytically cleaved during cornification in order to 
release filaggrin molecules (Gan et al., 1990). Upon release, filaggrin becomes crosslinked to 
the cornified envelope and thus contributes to the coordination of its structure. Furthermore, 
it aggregates keratin and other intermediate filament proteins into tight bundles, a 
hypothetical mechanism named 'ionic zipper' (Mack et al., 1993). This leads to the parallel 
alignment of keratin and subsequently to a change in cell shape from ellipsoid to flat. 
Filaggrin becomes degraded into free amino acids after a half live of 6 hours, which results in 
a high concentration of hydrophilic amino acids in the cornified cell. This is essential for the 
retention of water and thus for the osmolarity of the cell.  
Taken together, in humans the genes encoding involucrin, loricrin, profilaggrin and SPRs 
are all located in the epidermal-differentiation complex locus on chromosome 1q21 (Mischke 
et al., 1996). In addition to the aforementioned proteins, genes encoding late envelope 
proteins (LEPs) are also located in this locus. Late envelope proteins are a new family of 
proteins that are also substrates for TGs and that are expressed later during keratinocyte 
differentiation than SPRs. 
The assembly of the cornified envelope, which starts in the upper stratum spinosum, is 
mainly triggered by increasing Ca2+-levels. The increase in the Ca2+-gradient regulates Ca2+-
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dependent proteases, which are required for various processes during terminal differentiation 
(Hennings et al., 1980; Yuspa et al., 1989). They are responsible for the proteolytic 
processing of the cornified envelope precursor, the degradation of nuclei and mitochondria 
and the proteolysis of corneodesmosomes during desquamation (Kim et al., 1998). The 
proteases µ-calpain, cathepsin D and furin are responsible for the proteolytic processing of 
TGs, which results in their activation. PEP1, capain, furin and matriptase are required for the 
processing of filaggrin (List et al., 2003; Yamazaki et al., 1997).  
Once the cornified envelope is formed, the cell becomes embedded in a lipid envelope, 
which is essential for the barrier formation of the epidermis and helps to avoid transepidermal 
water loss. Skin lipids are mainly ceramides, cholesterol, fatty acids and cholesterol esters. 
Their precursors, glucosylceramides, phospholipids and cholesterols are synthesized 
intracellularly and stored in lamellar bodies. Beside these lipids, lamellar bodies also contain 
hydrolytic enzymes, including acid hydrolases (Hamanaka et al., 2005). During cornification 
the lamellar bodies are extruded into the extracellular space in the upper granular layer, 
where the activity of the hydrolases leads to complex changes in lipid composition (Freinkel 
and Traczyk, 1985; Menon et al., 1992). The exocytosis of these lipids is triggered by the 
increasing Ca2+-level in the differentiating cell at the stratum granulosum/stratum corneum 
interface. Although it has not been completely determined how the extracellular lipids are 
connected to the cornified envelope, it is known that long-chain ω-hydroxyceramides located 
on the extracellular surface are covalently attached through ester linkages to the outer 
surface of the cornified envelope (Nemes et al., 1999). In addition, other constituents of the 
lipid envelope have long fatty-acid chains that can cross the plasma membrane and become 
ester-linked to the cornified envelope.  
As one of the last steps of terminal differentiation the cells undergo programmed cell 
death. The cornified- and the lipid envelope are formed and replace the plasma membrane, 
the organelles are destroyed and the DNA is degraded (Houben et al., 2007; Lippens et al., 
2005). However, the programmed cell death of keratinocytes is distinct from the typical 
apoptosis. First the terminally differentiated corneocytes are not phagocytosed, and second 
pathways involved in apoptosis, including the caspase pathway, are not or differently 
activated. In contrast, the latest member of the caspase family, caspase 14, was found to be 
exclusively expressed and activated in the epidermis and not during typical apoptosis, 
suggesting a role for caspase 14 in programmed cell death of keratinocytes (Eckhart et al., 
2000; Lippens et al., 2005). Furthermore, the nucleus in cornified cells is completely 
degraded, whereas it is only partially degraded and nuclear fragments are still detectable 
during apoptosis (Candi et al., 2005). The DNAse responsible for the nuclear degradation 
and the pathways that lead to this degradation have not yet been identified. The final step of 
keratinocyte terminal differentiation and migration is the desquamation, the final shedding of 
corneocytes from the cell surface. This requires a controlled destruction of cell-cell adhesion 
structures, especially corneodesmosomes (Chapman and Walsh, 1990). 
Corneodesmosomes contain the cadherins desmoglein 1 and desmocollin 1, and the 
glycoprotein corneodesmosin, which is covalently linked to the cornified envelope. For the 
final shedding, these proteins need to be proteolytically degraded to allow desquamation 
(Houben et al., 2007). The epidermal homeostasis is a sensitive system that relies on a well-
adjusted balance between proliferating cells, which give rise to committed cells and cells that 
are lost by desquamation.  
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1.1.1.2 The basement membrane and the role of laminin and collagen 
 
The basement membrane includes a layer of extracellular matrix with a bi-layer structure 
that is divided into the lamina lucida, the clear layer underneath the basal layer, and the 
lamina densa, the electron dense layer closer to the dermis (McMillan et al., 2003). The 
basement membrane acts to determine the polarity of the epidermis. In a healthy skin, 
homeostasis is ensured by an exchange of signals between the dermis and epidermis. The 
components of the basement membrane need to selectively facilitate or prevent these 
signals from crossing. The epidermis and the dermis both contribute to the basement 
membrane formation (Fuchs and Raghavan, 2002). The basic components of the basement 
membrane are laminins, collagen IV, nidogens and heparan sulfate proteoglycans, but 
laminins are the major component, and together with collagen IV, form the basic scaffold of 
the basement membrane. Laminins are heterotrimeric glycoproteins composed of α, ß and γ 
chains (Aumailley et al., 2003). There are 5 distinct α, 4 ß and 3 γ chains, which give rise to 
15 laminin isoforms. The majority of laminins are able to form networks through self-
aggregation by binding their N-terminal short arms that carry binding sides for nidogens or 
collagen VII. This self-aggregation leads to the incorporation of laminins into the basement 
membrane. The predominant isoform of laminin in the basement membrane is laminin 5 (also 
called laminin 3-3-2) (Nishiyama et al., 2000). It consists of three non-identical α3, ß3 and γ2 
Figure 1: Schematic illustration of the epidermal architecture. The epidermis is a stratified epithelium 
consisting of stratum basale, stratum spinosum, stratum granulosum, stratum lucidum and stratum corneum. The 
cells are connected to each other by adherens junctions and desmosomes, and to the basement membrane by 
hemidesmosomes and focal adhesions. Cells of the stratum granulosum contain keratohyalin granules, which 
contain profilaggrin. 
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chains. Due to proteolytic processing laminin 5 has unusually short arms, especially at the α3 
and γ2 chains, which prevent the self-aggregation (Aumailley et al., 2003). In contrast to 
other laminins, laminin 5 does not bind nidogen, a member of the nidogen family of 
basement membrane glycoproteins that connects the collagen and laminin networks. 
Laminin 5 incorporates into the basement membrane by forming complexes with laminin 6 
and 7 that in turn can self-associate and interact with collagen IV through nidogen 
(Champliaud et al., 1996). Collagen IV is found primarily in the epidermal-dermal basement 
membrane. Its C-terminal C4 domain is not translationally processed, allowing a head-to-
head linkage of the collagen fibers. Collagen IV trimers carry a C-terminal NC-1 domain and 
are able to self-associate to form dimers through the N-terminal domains (Brown and Timpl, 
1995). In contrast to other collagen types collagen IV lacks a glycine in every third amino-
acid residue, which leads to a flexible sheet formation. 
Besides indirect collagen IV binding, laminin 5 can bind directly the NC-1 domain of 
collagen VII, via the ß3 and γ2 chain short arms (Chen et al., 1999). Collagen VII monomers 
are composed of 3 α1 chains folded into a triple helix, which then form disulfide-bond 
stabilized antiparallel-dimers. These dimers then bundle laterally into the so called anchoring 
fibrils. The anchoring fibrils extend from the lamina densa, where they are bound by laminin 5 
at their large NC-1 domain, to the papillary connective tissue (Rousselle et al., 1997). In the 
connective tissue, these fibrils either loop back to the lamina densa or enter the anchoring 
plaques (Gipson et al., 1987). Furthermore, other laminin isoforms are present in the 
basement membrane, but their expression is temporally and spatially restricted during 
development. For example, during embryogenesis laminin 10 is expressed throughout the 
entire basement membrane, but becomes restricted to the hair follicles in later stages. In 
addition, laminin α1 is expressed by the early periderm throughout the basement membrane 
except for the hair follicles and is then downregulated, whereas the expression of the isoform 
laminin α2 is restricted to the area surrounding the hair follicles (Aumailley and Rousselle, 
1999).  
 
 
1.1.1.3 Hemidesmosomes and focal adhesions 
 
The cells of the basal layer are strongly connected to the basement membrane by focal 
adhesions and hemidesmosomes (Figure 2). In both adhesion complexes, integrin receptors 
play both a structural role, mediating physical attachment of basal cells to the basement 
membrane, and a signaling role ensuring cellular proliferation and migration.  
Focal adhesions contain a transmembrane core of α3ß1 integrin, which is intracellularly 
connected to the actin and microtubule network of the cell. This connection is mediated by 
numerous actin-binding proteins, including paxillin, vinculin, talin, kindlin, migfilin, and actin 
isoforms by which the α3ß1 integrin is associated with actin (DiPersio et al., 1997). Integrin-
α3ß1 adheres extracellularly to laminin 5 and this binding is important for assembling and 
organizing the basement membrane. The ß1 and α3 integrins are generally involved in the 
development of hair follicles, but keratinocyte-specific ß1 integrin null mice show extensive 
epidermal blistering and exhibit a hyperproliferative epidermis (Brakebusch et al., 2000; 
DiPersio et al., 1997). In contrast, the ablation of α3 leads to hair loss and basement 
membrane assembly defects around hair follicles. The fact that no further defects have been 
described so far suggests that other integrins can compensate for the function of α3 (DiPersio 
et al., 1997). Basal keratinocytes also express several other isoforms including α2ß1, α5ß1, 
α9ß1, and αvß5. These isoforms have various ligands, including fibronectin, collagen and 
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laminin, suggesting that multiple interactions are involved in anchoring basal keratinocytes 
according to the physiological or pathological situation (Fuchs and Raghavan, 2002).  
Hemidesmosomes ensure a stable and robust adhesion of basal keratinocytes to the 
basement membrane and the underlying dermis (Borradori and Sonnenberg, 1999). The 
transmembrane components of hemidesmosomes are α6ß4 integrin and the 180kDa bullous 
pemphigoid antigen (BP180, also known as BPAG2, collagen type XVII α1 or COL17A1) 
(Hopkinson et al., 1992; McMillan et al., 2003). The cytoplasmic domain of BP180 interacts 
with the ß4 subunit, while the extracellular domain can bind to both, the α6 and the ß4 subunit. 
The ß4 subunit of the α6ß4 integrin heterodimer exhibits an unusually long cytoplasmic tail of 
over 1000 amino acids, which is required for the correct localization within the 
hemidesmosome and for the interconnection with other hemidesmosomal constituents. The 
cytoplasmic domains of α6ß4 integrin and BP180 are bound to the cytoplasmic plaque 
constituents bullouse pemphigoid antigen 230 (BP230, also named BPAG1e) and plectin 
(Hopkinson and Jones, 2000; Simpson et al., 2011). BP230 and plectin belong to the plakin 
protein family and have the ability to associate with keratin intermediate filaments, providing 
the bridge between the transmembrane proteins of the hemidesmosomes and the 
cytoskeleton. Extracellularly the α6ß4 integrin heterodimers serve as receptors for laminin 5 
(Dowling et al., 1996). This complex consisting of the extracellular portions of the 
hemidesmosomes and the bound laminin 5 is known as the anchoring filaments, which are 
attached to the anchoring fibrils (see chapter “1.1.1.2 The basement membrane and the role 
of laminin and collagen”) to provide a stable adherence of keratinocytes to the underlying 
basement membrane (Tsuruta et al., 2011). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Schematic diagram of focal adhesions and hemidesmosomes. Both are anchored in the basement 
membrane and the dermis through Laminin and anchoring fibrils. In focal adhesions, α3ß1 integrin serves as a laminin 
receptor, and intracellularly ß1 integrin is connected to the actin filaments through Migfilin, Kindlin and Talin.  
Hemidesmosomes are connected by α6ß4 integrin to BP230 and plectin, which bridge to the kertain filaments, to 
provide strong adhesion of the cells to the basement membrane and dermis.  
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1.1.1.4 Cell-cell adhesion 
 
In order for the skin to provide a barrier and protective function, epidermal cells need to be 
tightly connected to each other through complex junctions (Figure 1). In metabolically active 
layers, adherens junctions and desmosomes accomplish the formation of an essential sheet.  
Adherens junctions consist of the transmembrane protein E-cadherin which is connected 
to the E-cadherin of the neighboring cells. E-cadherin is connected intracellularly to two 
proteins, ß-catenin and p120-catenin. ß-catenin recruits α-catenin, which directly binds to the 
actin filaments of the cell, whereas p120-catenin counteracts cadherin endocytosis and 
degradation (Perez-Moreno and Fuchs, 2006; Simpson et al., 2011).  
Desmosomes are composed of transmembrane desmosomal cadherins, desmocollin and 
desmoglein, that bridge the gap between neighboring cells. The cytoplasmic tails of these 
cadherins are bound to plakoglobin, a member of the catenin family that mediates the 
association between desmosomal cadherins and desmoplakin, the major component of 
desmosomes. As already mentioned, desmoplakin is N-terminally connected to desmocollin 
and desmoglein via plakoglobin. The C-terminus of desmoplakin links the transmembrane 
part of desmosomes and the keratin intermediate filaments, thereby ensuring a strong 
binding to adjacent cells (Garrod, 1993; Simpson et al., 2011).  
 
 
1.1.1.5 Stem cells of the interfollicular epidermis 
 
The homeostasis of the epidermis and its appendages is ensured by stem cells, which 
contribute to the maintenance and repair of the interfollicular epidermis, the hair follicles and 
the sebaceous glands. These stem cells are characterized by their ability to self-renew and 
also to give rise to differentiated cells. It is known that stem cells exist in the interfollicular 
epidermis, and that these epidermal stem cells reside in the basal layer of the epidermis. It 
was shown that the continuous replacement of terminally differentiated cells is mediated by 
the presence of so called epidermal proliferation units (EPUs) that are distributed all over the 
interfollicular epidermis. The EPUs are organized in stacks of cells with a hexagonal surface 
area on top of 10-11 tightly packed basal cells. It was hypothesized that one EPU harbors 
one epidermal stem cell and 9-10 transit amplifying (TA) cells, which divide for a few times 
before differentiating (Potten, 1974, 1981). In contrast, recent studies demonstrated that the 
basal layer contains only one type of progenitor (named committed progenitors), which 
choose randomly between self-renewal and differentiation and that these cells have unlimited 
proliferation capacity (Clayton et al., 2007). Further studies questioned the existence of 
EPCs and postulated that proliferation of committed progenitors may be achieved simply by 
contact inhibition, when a nearby postmitotic cell delaminates from the basal layer. This 
would enable the epidermis to react to the demand for differentiated cells (Doupé et al., 
2010). 
Furthermore, it was long believed that basal cells divide symmetrically, but recent studies 
show that basal cells also divide asymmetrically giving rise to one committed cell and one 
proliferative basal stem cell (Lechler and Fuchs, 2005). Important factors, and possible 
markers during asymmetrical division are ß1 integrin and α-catenin which both play a role in 
cell-cell adhesion or cell adhesion to the basement membrane. Loss of function experiments 
showed that both factors are essential for a proper spindle orientation. Moreover, it was 
shown that basal cells with the highest ß1 integrin level have the highest proliferative and 
attachment potential, whereas the cells with lower ß1 level detach and terminally differentiate 
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(Jones and Watt, 1993). The vast majority of these divisions show a perpendicular mitotic 
spindle orientation giving rise to two cells persisting in the basal layer. The remaining 
divisions show a planar spindle orientation with one basal stem cell that resides at the basal 
layer and one committed suprabasal cell. 
 
 
1.1.2 Molecular pathways involved in keratinocyte terminal differentiation 
 
1.1.2.1 P63 
 
During the differentiation and migration process of keratinocytes in the epidermis, the first 
transcription factor specifically expressed in this process is p63. It belongs to the p53 tumor 
suppressor gene family (Kaghad et al., 1997). The two major p63 isoforms comprise 16 
exons and are expressed from two different promoters. The two major isoforms are TAp63 
which has an N-terminal transactivator domain, and ∆Np63 which lacks this domain. 
Alternative splicing of these major isoforms at the C-terminus generates further isoforms 
named α, ß, γ, and δ. The premature transcriptional termination in exon 10 lead to an 
additional ε-isoform (Mangiulli et al., 2009). Gain and loss-of function studies revealed that 
p63 plays an important role in the maintenance of the proliferative potential of basal cells, as 
well as for the initiation of stratification (Koster et al., 2004b). Furthermore, it is highly 
expressed in basal cells. The ∆Np63 isoforms are the predominant isoforms in the adult 
epidermis and have a dominant-negative effect on TAp63 isoforms (Yang et al., 1998). 
∆Np63α favors cell proliferation through binding to the promoters of p21WAF/Cip1 and 14-3-3σ 
(member of the 14-3-3 family of intracellular signaling proteins), thus inhibiting their 
transcription. The important role of p63 becomes apparent in mice lacking p63, which exhibit 
major defects in all stratified epithelia and die immediately after birth due to a missing 
protective barrier (Koster and Roop, 2007; Mills et al., 1999; Yang et al., 1999). The detailed 
role of the different p63 isoforms was unclear for a long time, and it was not known whether 
the predominant ∆Np63α or the TAp63α isoform regulates the commitment to stratification or 
the self-renewal potential. The most recent studies showed that p63-/- cells fail to express 
keratin 5 and keratin 14 as well as differentiation markers keratin 1 and loricrin. In contrast, 
these cells expressed keratin 18, which is normally expressed in adult single layered 
epithelia and during embryonic epithelial development prior to stratification. This fact lead to 
the suggestion, that p63 is essential for the switch from keratin 8 and 18 to keratin 5 and 14. 
Furthermore, gain-of-function experiments in cells which never express p63 or keratins 
revealed that only the TAp63α isoform was able to induce keratin 14 expression, whereas 
∆Np63α could not. It seems that the switch in expression from TAp63 isoforms to ∆Np63 
isoform is required to counterbalance the inhibitory effect of TAp63α on terminal 
differentiation and to allow keratinocytes to terminally differentiate (Koster and Roop, 2004). 
 
 
1.1.2.2 Notch 
 
One of the major signaling pathways which is crucial during the early commitment of 
epidermal differentiation is the canonical Notch pathway. Notch is a cell surface receptor and 
is activated upon binding to its ligands, which are expressed by neighboring cells. Mice and 
humans have four Notch homologues and various ligands of the Delta and Jagged family. 
Notch receptors and ligands are expressed in the basal and suprabasal (spinous and 
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granular) layers (Watt et al., 2008). The binding of Notch ligands to the receptor results in the 
cleavage of the intracellular Notch domain (NICD) and its translocation into the nucleus 
where it forms an active transcriptional complex with the recombinant binding protein 
suppressor of hairless (RBP-Jκ) to build a bipartite transcription factor (Blanpain and Fuchs, 
2006; Rangarajan et al., 2001; Watt et al., 2008). Notch turns this suppressor into an 
activator of Notch target genes, including HES and HEY family genes. These transcriptional 
changes are required for the detachment of basal cells from the basement membrane and 
the commitment to spinous differentiation (Blanpain and Fuchs, 2006; Rangarajan et al., 
2001). In vitro studies revealed that the addition of the Notch ligand JAG-1 to keratinocyte 
cultures resulted in Notch activation and subsequently, during the formation of the cornified 
envelope, in an induction of loricrin, involucrin, and the peroxisome proliferation activated 
receptor γ (PPAR γ) expression (Nickoloff et al., 2002). Furthermore, Notch enhances the 
levels of nuclear factor kappa of activated B-cells (NF-κB) (Guan et al., 1996). These studies 
indicated that NF-κB works in concert with Notch during epidermal development. 
Furthermore, RBP-Jκ was shown to bind to the promoter of the cyclin-dependent kinase 
inhibitor 1 (p21WAF/Cip1), a well-known cell cycle regulator. This indicates that p21WAF/Cip1 is a 
direct target of Notch signaling (Rangarajan et al., 2001), which not only influences the 
commitment of basal cells to differentiation but also the withdrawal from the cell cycle.  
 
 
1.1.2.3 NF-κB and IKK 
 
The nuclear factor kappa of activated B-cells (NF-κB) transcription factor is a dimer 
composed of combinations of structurally related proteins, including p50, p52, p65, c-Rel and 
RelB (Verma et al., 1995). In resting cells NF-κB is inactive and located in the cytoplasm, 
where it is bound to the NF-κB inhibitory proteins α and ß (IκBα and IκBß). Upon stimulation 
by tumor necrosis factor α (TNFα), interleukin-1 α (IL-1α), UV irradiation or infection, IκBs are 
phosphorylated by IκB kinases leading to their degradation and the translocation of NF-κB 
into the nucleus (Seitz et al., 1998), where the activated form regulates the transcription of 
target genes. In mammalian skin, NF-κB activity is mediated in part by p50 and p65 subunits 
(Qin et al., 1999). In the basal layer NF-κB is found to persist in its inactive, bound form in the 
cytoplasm, whereas suprabasal cells show a nuclear localization of NF-κB. The fact that NF-
κB becomes activated in committed cells that withdraw from the cell cycle led to the 
conclusion, that NF-κB plays a role in the switch from proliferation to growth arrest (Seitz et 
al., 1998). Similar to p63 and Notch, NF-κB induces p21WAF/Cip1 thus inducing growth arrest in 
cells, rather than inducing the expression of differentiation markers (Seitz et al., 2000). 
Besides this, it opposes the proliferative activity of TNFR1/JNK during development, 
demonstrating an orchestrated network of different pathways that are involved in the 
proliferation/differentiation switch. In contrast to its role as an NF-κB activator, the inhibitor of 
kappa B kinase α (IKKα) also promotes epidermal differentiation independently of NF-κB 
function. IKK is an enzyme complex composed of three polypeptides IKKα, ß and γ, where 
IKKβ represents the catalytic and IKKγ the regulatory subunit. It was shown that the ablation 
of IKKα results in highly proliferative basal and spinous layers and that granular and cornified 
layers fail to form (Hu et al., 2001). Furthermore, mutation of the kinase domain of IKKα 
demonstrated that the kinase activity was not responsible for the induction of differentiation 
markers like loricrin or filaggrin. It is still not known how IKKα induces the expression of 
differentiation markers, nor if other proteins are involved in the interaction (Hu et al., 2001). 
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1.1.2.4 AP-1  
 
The activator protein 1 (AP-1) transcription complex is composed of one protein of the Jun 
protein family that forms a homodimer with another Jun protein or a heterodimer with a 
member of the Fos-protein family (Hess et al., 2004). The AP-1 proteins share a conserved 
DNA-binding domain combined with a basic leucin zipper region (bZIP domain), which is 
responsible for the dimerization and stability of the dimer. In vitro experiments revealed that 
the knock-down of c-Jun results in a decreased expression of epidermal growth factor 
receptor (EGFR) and its ligand HB-EGF and the cells proliferate less and differentiate faster 
(Zenz et al., 2003). Furthermore, it was shown that AP-1 is involved in a paracrine loop 
where IL-1 secreted by keratinocytes induces c-Jun in dermal fibroblasts which then produce 
keratinocyte growth factor (KGF) and granulocyte-macrophage colony stimulating factor 
(GM-CSF). This process leads to the stimulation of cell growth and proliferation of 
keratinocytes (Maas-Szabowski et al., 2001; Szabowski et al., 2000). Further studies 
revealed the involvement of AP-1 in the expression of loricrin (DiSepio et al., 1995), 
involucrin (Takahashi and Iizuka, 1993) and TG1 (Liew and Yamanishi, 1992), which can be 
explained by the presence of conserved AP-1 binding sites in the promoters of many 
differentiation specific genes. 
 
 
1.1.2.5 AP-2 
 
AP-2 consists of five different isoforms AP-2α-ε; encoded by five different genes (Hilger-
Eversheim et al., 2000). AP-2 binding sites are found in the promoter regions of several 
keratinocyte differentiation markers, including TG1 (Mariniello et al., 1995), involucrin 
(Kachinskas et al., 1994), p21WAF/Cip1 (Zeng et al., 1997), as well as K5 and K14 (Byrne et al., 
1994; Leask et al., 1991). Even though Ap-2α-/- mice have a normal phenotype, they show 
increased K1 levels (Maytin et al., 1999). The exact role of AP-2 is still unclear, but the 
existence of AP-2 binding sites in epidermal genes suggests a necessary, but not sufficient, 
involvement of AP-2 in epidermal gene regulation (Leask et al., 1991). 
 
 
1.1.2.6 BMPs 
 
Bone morphogenic proteins (BMPs) are the largest family of secreted molecules of the 
transforming growth factor (TGF)-ß superfamily. They have versatile functions including the 
regulation of development, proliferation, differentiation and apoptosis in various organs 
(Botchkarev, 2013; Li et al., 2003; Mishina, 2003).  
BMP signaling is mediated upon BMP binding to its receptors BMPR-I and BMPR-II. While 
the individual type I and type II receptors display low affinity to BMPs, the heterotetrameric 
complex of type I and type II receptors shows high-affinity binding to BMPs. Binding of BMP 
to its receptors leads to the phosphorylation of the intracellular type I receptor domain by 
type II receptor kinase, resulting in the transmission of an extracellular signal into the interior 
of the cell. BMP activates two intracellular signaling pathways upon binding to its receptor 
complex: The “canonical” signaling pathway that includes the Smad family of proteins and 
the “noncanonical” BMP-mitogen-activated protein kinase (MAPK) pathway.  
In the “canonical” pathway, Smad1, Smad5 and Smad8 are activated through receptor 
type I mediated phosphorylation (now termed receptor-activated Smad, or R-Smad), 
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assemble with Smad4 (co-Smad) and translocate into the nucleus where they regulate BMP 
target genes. Other Smads, like Smad6 and Smad7 (inhibitory Smads, I-Smads) antagonize 
the phosphorylation of Smad1, Smad5 or Smad8, probably through competition with Smad4 
for binding to Smad1 (Hata et al., 1998). In the nucleus the Smad complex binds to co-
activators or co-repressors and thus activates or inhibits target genes (Kusanagi et al., 2000; 
Li et al., 2001), including Dlx-3, keratin 1 or involucrin (D’Souza et al., 2001; McDonnell et al., 
2001; Park and Morasso, 2002). To date, Smad proteins are the only direct substrates which 
mediate gene response to the TGF-ß family (Massagué, 2012). 
The “noncanonical” pathway is initiated through the activated BMPR complex, interacting 
intracellularly with the adaptor protein XIAP, which links TGF-ß activated kinase 1 binding 
protein (TAB1) to the BMPR complex, and TAB1 in turn activates TGF-ß activated kinase 1 
(TAK1) (Yamaguchi et al., 1999). TAK1 belongs to the MAPK kinase kinase family and is 
activated upon TGF-ß1 and BMP4 stimulation (Botchkarev et al., 2002). Once activated 
TAK1 induces distantly MAPK family member Nemo-like kinase (NLK) which then inhibits the 
phosphorylation of TCF/Lef1 transcription factors and downregulates Wnt/ß-catenin-
dependent transcription (Ishitani et al., 1999). Furthermore, Smad6 was shown to bind and 
inhibit TAK1, suggesting a link between the canonical and noncanonical pathways (Kimura et 
al., 2000).  
In the embryonic murine epidermis BMP7 is present in the basal layer, whereas BMP6 is 
located in the suprabasal layer (Lyons et al., 1989; Takahashi and Ikeda, 1996; Wall et al., 
1993). The BMP receptor BMPR-IA is largely restricted to proliferating cells in the basal 
layer. In contrast, BMPR-IB is associated with differentiation and expressed in subrabasal 
layers (Botchkarev et al., 1999; Panchision and Pickel, 2001). In addition, Smad1, 5 and 6 
are also expressed in the developing murine epidermis, suggesting a strong role during 
development (Dick et al., 1998; Flanders et al., 2001). In the adult human epidermis, BMPR-
IA, BMPR-IB and BMPR-II are restricted to suprabasal keratinocytes, whereas no BMP 
receptors are seen in basal cells (Hwang et al., 2001). Also BMP2 and BMP6 were shown to 
play a role in the postnatal murine epidermis. BMP6 stimulates K1 and involucrin (D’Souza et 
al., 2001) expression through the canonical pathway and BMP activates Dlx-3 transcription 
factor by recruiting Smad1 and Smad4 (McDonnell et al., 2001; Park and Morasso, 2002). 
Even though not all BMP targets are known yet, it has an important influence on the 
development, differentiation and proliferation in the epidermis. 
 
 
1.1.2.7 C/EBP 
 
The CCAAT/enhancer binding protein (C/EBP) family of transcription factors is 
characterized by a conserved basic-leucine zipper (bZIP) domain at the C-terminus that 
binds to CCAAT-motifs in the regulatory region of target genes. This domain allows C/EBPs 
to form homo- and heterodimers with other family members and with other unrelated 
transcription factors. The family comprises six members (C/EBPα-C/EBPζ) (Ramji and Foka, 
2002) and is classified into the class of leucin zipper transcription factors. C/EBPs were 
suggested to play a role in controlling cell proliferation and differentiation, since levels of 
C/EBPα and C/EBPß increased significantly in response to calcium-induced differentiation 
(Maytin and Habener, 1998). The expression patterns of C/EBPs vary within the epidermis; 
C/EBPα is expressed in the upper suprabasal layers, whereas C/EBPß is already detectable 
in low amounts in the cytoplasm of basal cells and in the nucleus of suprabasal cells (Maytin 
and Habener, 1998; Oh and Smart, 1998). Both were shown to be able to bind to the K10 
promoter and activate the expression of K10. C/EBPα and C/EBPß are good examples for 
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the complex network driving keratinocyte differentiation, since their expression is also 
dependent on AP-2. AP-2 and C/EBPß are both present in the basal layer, where AP-2 
represses the expression of C/EBPα. In upper suprabasal layers, the expression of AP-2 is 
extinguished and C/EBPß is replaced by C/EBPα (Maytin et al., 1999).  
 
 
1.1.2.8 MAPK/ERK-Pathway 
 
The mitogen-activated protein kinase pathway (MAPK) is a critical regulator for the 
balance between proliferation and differentiation in keratinocytes (Scholl et al., 2007). During 
normal homeostasis the pathway is mediated by ligand binding to tyrosin kinase receptors, 
such as epidermal growth factor receptor (EGFR) or by basal integrins, and is negatively 
regulated by adhesion molecules. It was shown that reduced EGF signaling resulted in lower 
proliferation rates, whereas the constitutive EGFR activation increased proliferation (Janes 
and Watt, 2006). The pathway is initiated upon ligand binding, which activates the tyrosine 
kinase activity of the cytoplasmic domain of EGFR and tyrosine residues become 
phosphorylated. This leads to the binding of growth factor receptor-bound protein 2 (Grb2) to 
the phosphotyrosine residues of EGFR. Grb2 in turn binds SOS1 (son of sevenless; family of 
guanine nucleotide exchange factors (GEFs)), which once activated, promotes the removal 
of GDP from Ras. This allows Ras to bind GTP and subsequently activate the kinase activity 
of Raf. Activated Raf can phosphorylate and thus initiate Mek, which then in a last step 
phosphorylates and activates extracellular signal-regulated kinases (Erk). Erk regulates the 
activity of various transcription factors, including c-Myc, c-Fos genes and transcription factors 
that are important for cell cycle and proliferation.  
Many studies which dealt with the role of the MAPK/Erk pathway in keratinocytes 
investigated the role of Ras during development and differentiation. It was shown that 
constitutive expression of Ras in the basal layer leads to hyperproliferation and impaired 
differentiation. The induced expression of Ras in suprabasal layers led to a milder response 
with focal hyperplasia (Dajee et al., 2002). These data indicate a more influential role of Ras 
in basal keratinocytes in maintaining cells in a proliferative, undifferentiated state.  
Furthermore, Mek1/Mek2 double knock-out mice die 24h after birth due to dehydration 
and loss of barrier function. The conditional deletion of Mek1 and Mek2 in adulthood resulted 
in tissue death, indicating that the MAPK/Erk pathway has an additional effect on cell viability 
(Scholl et al., 2007). Taken together, these data demonstrate, that the MAPK/Erk-pathway 
plays a central role for the viability and proliferation of keratinocytes.  
 
 
1.1.2.9 Hox genes 
 
The homeobox (Hox) gene family of transcription factors consists of various crucial 
regulators of axial patterning and organogenesis. All Hox genes have a conserved binding 
sequence, named homeodomain or homeobox, and are present in vertebrates and 
invertebrates. To date, 39 Hox genes were identified in vertebrates and classified in four 
groups A-D. About 30 Hox genes were found to be expressed in fetal and/or adult human 
skin (Detmer et al., 1993; Li et al., 2002). In the embryonic epidermis Hox gene expression is 
limited to the basal layer, whereas in mature epidermis it is significantly down regulated and 
restricted to the granular layer (Mack et al., 2005). Hox gene function varies depending on 
the gene, the environment and developmental stage of the organism. They can either 
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promote proliferation and suppress differentiation or prevent proliferation and allow 
differentiation. HoxA7, for instance, is activated in proliferating cells and down-regulated in 
committed cells. It was shown that HoxA7 downregulates TG1, thus lower HoxA7 levels in 
upper epidermal layers would favor the cross-linking by TG1, which is essential for 
differentiation (La Celle and Polakowska, 2001). In contrast, HoxB13 is upregulated in 
committed keratinocytes and seems to have an ant-proliferative function (Economides et al., 
2003; Kömüves et al., 2003).  
Recent studies revealed that a few genes from the group 13 of Hox proteins interact with 
Smad proteins (Williams et al., 2005). 
Taken together, these data demonstrate that Hox genes are essential regulators of 
development, proliferation and differentiation in many different tissues.   
 
 
1.1.3 The skin appendages  
 
1.1.3.1 The hair follicle 
 
The hair follicle morphogenesis begins with an aggregation and invagination of epidermal 
cells to form the follicular placode. This formation is induced by yet unknown signals from the 
underlying mesenchyme as well as from neighboring epidermal cells, but ß-catenin is 
believed to be one of the effectors of this signal (Millar, 2002). The placode signals back to 
induce condensation in the underlying dermis, and this aggregation of cells will later become 
the dermal papilla. Initiators of this process are cytokines, receptors and signaling molecules 
known as placode promoters and placode inhibitors (Millar, 2002). The phase of downward 
growing through the dermis into the subcutaneous fat is termed elongation phase or anagen 
phase. The leading front of the elongating hair follicle are the highly proliferative matrix cells, 
which surround the hair follicle. After elongation is complete, the matrix cells at the bulb 
region continue to proliferate to give rise to differentiated cells that migrate upwards to build 
the inner root sheath (IRS) and the hair shaft (Legué and Nicolas, 2005). The IRS cell 
specification is regulated by BMP and Notch signaling and by the action of transcription 
factors like CDP and GATA3 (Blanpain and Fuchs, 2006). Furthermore, the IRS acts as a 
channel to lead the hair shaft to the epidermal surface. The outer root sheath (ORS) 
surrounds the hair follicle, is continuous with the basal layer of the epidermis and contains 
the hair bulge below the sebaceous gland, the stem-cell containing niche of the hair follicle. 
Studies used nucleotide labels in pulse-chase experiments to show that slow-cycling label-
retaining cells reside within the bulge (Blanpain and Fuchs, 2006; Cotsarelis et al., 1990; 
Taylor et al., 2000). Upon activation these stem cells exit the bulge and start to proliferate to 
give rise to a new hair follicle, populate the epidermis during wound healing and maintain the 
sebaceous gland (Fuchs and Horsley, 2008). Increased BMP signaling was detected in bulge 
cells, suggesting a role for BMP in the stem cell control (Blanpain et al., 2004; Morris et al., 
2004; Tumbar et al., 2004).  
The phase of hair follicle initiation is followed by a degenerative phase or catagen phase. 
The stop of hair proliferation, involution of the hair and apoptosis of matrix cells accompanied 
by the loss of two thirds of the hair follicle are characteristics of the catagen phase. The 
catagen phase ends when an epidermal strand guides the dermal papilla upwards to reach 
the bulge region. The hair follicle enters now a restoring (telogen) phase during which the 
bulge anchors the old hair and rests before entering the next hair cycle (anagen phase). The 
new cycle is initiated by signals between the dermal papilla and the overlying epithelium of 
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the hair follicle (Davidson and Hardy, 1952; Fuchs et al., 2001). Another important pathway 
in hair follicle morphogenesis is the Wnt-signaling pathway; especially the nuclear ß-
catenin/lymphoid enhancer binding factor 1 (Lef1)/T cell factor 3 (TCF3) complex, as well as 
BMP and FGF family members are also important regulators (Fuchs et al., 2001).   
In postnatal life, the upper portion of the hair follicle and the dermal papilla in the bulb 
persist, whereas the remaining parts cycle through anagen, catagen and telogen phases 
(Fuchs et al., 2001). 
 
 
1.1.3.2 The sebaceous gland 
 
The development of the sebaceous gland (SG) takes place at the same time as the hair 
follicle morphogenesis. The specialized cells of the SG are lipogenic cells, termed sebocytes, 
which produce lipids and sebum. Sebum consists of lipids, and through its oily substance it 
maintains the water resistance of the hair and the skin surface. Terminally differentiated 
sebocytes release the sebum into a duct and onto the skins surface. Even though the stem 
cells from the bulge of the hair follicle have the capacity to differentiate into sebocytes, 
(Blanpain et al., 2004; Morris et al., 2004) pulse-chase experiments identified a pool of slow-
cycling progenitor cells in the gland, which maintains the constant turnover of mature 
sebocytes (Braun et al., 2003; Ghazizadeh and Taichman, 2001). Furthermore, it was shown 
that these cells are characterized by the expression of the transcription factor Blimp1 
(Horsley et al., 2006).  
The fate of sebocytes is a result of the inhibition of Wnt signaling. The active ß-
catenin/Lef1/Tcf3 complex induces the ectoderm to generate hair follicle, but if this complex 
is inhibited the cells become sebocytes (Han et al., 2006; Niemann et al., 2003; Takeda et 
al., 2006). In contrast, hedgehog signaling induces sebocyte development, even ectopically 
after induction (Allen et al., 2003). Taken together, inhibition of Wnt signaling as well as 
activation of hedgehog-signaling are both required for SG lineage specification. 
 
 
1.1.4 Non-keratinocyte cell types of the epidermis 
 
1.1.4.1 Merkel cells 
 
Merkel cells are found in the basal layer of the epidermis, either independently but mostly 
in clusters (touch domes) (Sidhu et al., 2005). They function as sensory mechanoreceptors 
and associate with sensory axons to form Merkel cell-neurit complexes.  
Merkel cells are the pressure sensors of the skin. Upon deformation by pressure Merkel 
cells release a neurotransmitter, which activates neurons that are located at the basement 
membrane. Furthermore, they are considered to be responsible for form and texture 
perception (Johnson, 2001). The developmental origin of Merkel cells is not completely 
resolved. Some studies describe a neural crest origin (Le Douarin, 1980; Halata et al., 2003) 
but there is also good evidence that these cells may have an epidermal origin (Loomis, 
2001).   
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1.1.4.2 Melanocytes 
 
Melanocytes are pigmented, dendritic cells located mostly in the basal layer of the 
epidermis. During development, melanocyte precursors termed melanoblasts arise from the 
neural crest and migrate through the dermis and the basement membrane to reach the 
epidermis. The density of melanocytes varies in different body regions with around one 
melanocyte per five to ten keratinocytes (Fitzpatrick and Breathnach, 1963).  
Melanocytes synthesize melanin in vesicles named melanosomes (Seiji and Fitzpatrick, 
1961). These vesicles are delivered to keratinocytes through cytoplasmic processes, to 
sustain a permanent passage of melanosomes (Ando et al., 2011). The melanosomes are 
then phagocytosed by the keratinocytes, which results in the aggregation of melanin around 
the nucleus to protect the nuclear DNA from UV irradiation (Montagna and Carlisle, 1991).  
 
 
1.1.4.3 Langerhans cells 
 
Langerhans cells originate in the bone marrow and comprise approximately 5% of all 
epidermal cells. They migrate into the epidermis and reside locally for extended periods with 
the highest concentration in the spinous layer (Jakob et al., 2001). Their numerous dendrites 
allow for antigen sampling of nearly the entire surface of the skin. Langerhans cells have an 
antigen-presenting function and represent a critical immunological barrier to the external 
environment. Upon inflammation, langerhans cells are mobilized by proinflammatory 
cytokines like TNF-α and interleucin 1 (IL-1) and migrate rapidly through the lymphatic 
vessels to the draining lymph nodes (Romani et al., 2001; Stoitzner et al., 2002). These cells 
are replaced by blood-borne precursors that migrate into the epidermis. Because of their 
elevated E-cadherin level, langerhans cells are thought to be anchored in the epidermis by 
the formation of junctions with keratinocytes. Besides E-cadherin, also TGF-ß also might be 
responsible for the retention of langerhans cells in the epidermis (Geissmann et al., 1999; 
Riedl et al., 2000). 
 
 
1.1.5 The embryonic development of the epidermis 
 
The embryonic development of a mammalian organism begins with the fertilization of the 
oocyte in the ampulla of the oviduct. Once fertilized, the zygote is guided by the cilia in the 
oviduct towards the uterus. During this migration the zygote begins to cleave. At the 8-cell 
stage, the zygote is now called blastomere, cell adhesion proteins, like E-cadherin, are 
expressed and the blastomere becomes a compact ball of cells. After additional cleavages, 
the 8-cell blastomere becomes a 16-cell morula, which consists of internal cells that are 
encased by external cells (Barlow et al., 1972). The surrounding external cells give rise to the 
trophoblast, whereas the inner portion of cells will become the inner cell mass (ICM). The 
trophoblast cells will form the tissue of the chorion, the extraembryonic membranes and parts 
of the placenta, whereas the ICM will give rise to the embryo. The segregation into ICM and 
trophoblast is the first differentiation event that takes place. Upon ongoing cleavages the 
trophoblast cells secrete fluids into the morula that generate a cavity, the blastocoel. The two 
cell types become more and more separated as the blastocoel expands, and the morula is 
now called the blastocyst. During migration the embryo is surrounded by a glycoprotein 
membrane, the zona pellucida, which prevents the implantation in the oviduct and a tubal 
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pregnancy. Once the blastocyst has reached the uterus it escapes from the zona pellucida 
and implants in the uterine wall (O’Sullivan et al., 2001; Perona and Wassarman, 1986). After 
that, the blastocyst adheres to the endometrium, the epithelial surface of the uterus that has 
been prepared for implantation by hormonal stimulation and implanting takes place 
(Ramathal et al., 2011; Wang and Dey, 2006).  
The ICM now forms two cell layers, the lower primitive endoderm and the upper epiblast. 
The primitive endoderm gives rise to extraembryonal structures, such as the yolk sac and is 
responsible for determining the side of the gastrulation, regulating cell movements in the 
epiblast and promotion of the maturation of blood cells (Stern and Downs, 2012). The 
epiblast gives rise to the embryo. Fibroblast growth factor (FGF) signaling within the ICM 
defines the final fate of either epiblast or primitive endoderm (Yamanaka et al., 2010).  
Epiblast and the primitive endoderm now form a structure that is named the bilaminar 
germ disc. 
The next step in development is the gastrulation, a process which proceeds similarly in 
birds, reptiles and mammals and which is initiated by the formation of a characteristic 
structure called primitive streak. The primitive streak extends through the midline of the 
bilaminar germ disc and creates the left-right and anterior-posterior body axes. It is formed 
by epiblast cells moving towards the midline of the embryo. Subsequently, these cells 
invaginate and migrate between the epiblast and the primitive endoderm which results in the 
formation of the primitive groove. The cells that invaginate form the endoderm and 
mesoderm. During this process the cells undergo epithelial-mesenchymal transition and 
decrease E-cadherin expression to loosen the cell-cell contacts (Burdsal et al., 1993). Cells 
of the primitive streak are capable of synthesizing FGF and responding to FGF signals, and 
these signals seem to be responsible for cell migration and specification (Ciruna and 
Rossant, 2001; Sun et al., 1999).  
The presumptive ectoderm is located anterior and lateral to the fully extended primitive 
streak. At the end of the primitive streak the neural plate is formed by the thickening of the 
ectodermal tissue. The neural plate invaginates to form the neural tube, which will later 
become the central nervous system. The margins of the neural plate break away from the 
neural plate and give rise to the neural crest which is the origin of the peripheral nervous 
system and of pigmented cells (melanocytes).  
The process that forms the three ectodermal compartments is called neurulation and 
relies on differential BMP expression. Whereas the specification into the epidermis requires 
high levels of BMP, cells with a very low level become neural plate and intermediate BMP 
expression favors the formation of neural crest (Archer et al., 2011).  
The epidermis of the embryo starts as a single layer but soon becomes a two-layered 
structure. The upper layer is termed periderm and represents a temporary cover to protect 
the embryo from dehydration. The inner layer is the basal layer and contains epidermal stem 
cells that divide asymmetrically to give rise to one stem cell and one differentiating daughter 
cell. The cells of the embryonic basal layer differ from the cells of the adult basal layer in that 
they express of keratin 8 and keratin 18, which are only expressed in adult single layered 
epithelia and in embryonic epidermis. The daughter cells leave the basal layer, migrate 
upwards and differentiate. These younger cells push older cells to the border of the skin thus 
generating a stratified epithelium consisting of four major layers (see paragraph “1.1.1 The 
skins architecture and homeostasis”). Important factors stimulating the development of the 
epidermis are BMPs. BMP signaling specifies the epidermis lineage by blocking neural fate 
and initiates epidermal production by inducing the expression of p63 transcription factor in 
the basal layer (see paragraph “1.1.2 Molecular pathways involved in keratinocyte terminal 
differentiation”)(Truong and Khavari, 2007).  
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1.2 Induced pluripotent stem cells 
 
1.2.1 History and discovery of induced pluripotency 
 
In 1981 Martin John Evans and Matthew Kaufman isolated embryonic stem cells (ESCs) 
from a mouse blastocyst, which was a major breakthrough in the field of biology (Evans and 
Kaufman, 1981). In the same year, Martin was able to establish a pluripotent stem cell line 
and culture these cells in a teratocarcinoma conditioned medium (Martin, 1981).  
Pluripotent cells have the ability to differentiate into any cell type of the mammalian body 
including the germ line and they can undergo symmetrical self-renewal to give rise to 
identical daughter cells. These capacities make them a powerful tool for studying 
developmental processes in healthy organisms. Furthermore, disease specific mutations 
carried by the stem cells allow the investigation into the development of diseases.  
Thirty years after the first isolation of mouse embryonic stem cells, Thomson and 
colleagues succeeded in isolating and culturing primate ESCs from Rhesus monkey 
(Thomson et al., 1995) and only three years later they isolated the first human ESCs 
(Thomson, 1998). The establishment of human ESCs (hESCs) not only stirred up hopes for 
various therapeutic applications but also raised ethical concerns. The opinions are divided as 
to when the embryo has a full moral status and from what point of time on it can be defined 
as a human being. For example, is there a so called cut-off point at 14 days after fertilization 
when the nervous system begins to develop? The regulations for using hESCs differ from 
country to country and make it difficult to use these cells. Therefore, alternative sources of 
pluripotent cells were examined and the question whether adult somatic cells are restricted to 
their fate was raised.  
Briggs and King could show by transferring nuclei from blastocyst into enucleated frog 
oocytes, which gave rise to swimming tadpoles that genes are not lost, or permanently 
silenced, after the cell fate was determined (Briggs and King, 1952). Furthermore, Gurdon 
transplanted a nucleus from a fully differentiated somatic frog cell into an enucleated egg that 
then gave rise to a living organism. He demonstrated that somatic cloning derived ECSs 
provide a new source of pluripotent cells, which are genetically identical to the host (Gurdon, 
1962). 
In 2006 Kazutoshi Takahashi and Shinya Yamanaka found out that the ectopic 
overexpression of defined factors reprogrammed mouse adult somatic cells into pluripotent 
stem cell like cells (Takahashi and Yamanaka, 2006) that show the same characteristics like 
embryonic stem cells. With this finding these authors created a great deal of enthusiasm in 
the scientific community and Yamanaka as well as Gurdon were honored with “The Nobel 
Prize in Physiology or Medicine in 2012 for the discovery that mature cells can be 
reprogrammed to become pluripotent” 
(http://www.nobelprize.org/nobel_prizes/medicine/laureates/2012/press.html).  
Takahashi and Yamanaka tested a panel of transcription factors and ectopically 
overexpressed them in mouse somatic cells. They demonstrated that the overexpression of 
four factors, octamer binding protein 4 (Oct4 or POU5F1), krueppel-like factor 4 (Klf4), sex 
determining region Y (SRY) box 2 (Sox2) and c-Myc resulted in the reprogramming into a 
pluripotent state and termed these cells induced pluripotent stem cells (iPSCs) (Takahashi 
and Yamanaka, 2006). IPS cells show comparable properties to embryonic stem cells, 
including self-renewal and the potential to differentiate into any cell type of the body. Since 
the first reprogramming experiment, many other adult cell types of different organisms have 
been reprogrammed (Galach and Utikal, 2011).  
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IPSCs offer the remarkable potential to study and manipulate the development of not only 
a cell type but also whole organs and open new possibilities for studying diseases and their 
treatment. 
 
 
1.2.2 Methods for generating induced pluripotent stem cells 
 
To date, many different methods for the reprogramming of adult cells into a pluripotent 
state have been established. The first approaches used retroviral transduction (Okita et al., 
2007; Takahashi and Yamanaka, 2006; Wernig et al., 2007). Retroviral vectors integrate 
stably into the genome and are usually silenced gradually during reprogramming. The 
silencing of the transgenes is very important for the generation of stable iPSCs. An iPSC line 
will only be considered as stably reprogrammed, when the endogenous pluripotency network 
is upregulated and the transgene has been silenced (Stadtfeld et al., 2008a). Regarding the 
fact that silenced genes can be reactivated and that each of the reprogramming factors is a 
potential oncogene makes stable silencing even more important (Friedmann-Morvinski and 
Verma, 2014).  
Even though the transduction efficiency of retroviruses is about 90%, the reprogramming 
efficiency remains rather low, about 0.01% to 0.1% in human fibroblasts (Stadtfeld and 
Hochedlinger, 2010).  
A slightly higher transduction efficiency is achieved by using lentiviral vectors (Blelloch et 
al., 2007; Yu et al., 2007), since it allows the transduction of dividing and non-dividing cells. 
The availability of inducible lentiviral vectors (Tet-ON system) offered the possibility of 
controlling the transgene expression (Stadtfeld et al., 2008a; Wernig et al., 2008). The use of 
recombinase-excisable systems enables even the removal of the transgene, but after 
excision short vector sequences (loxP sites) remain in the host genome. The efficiency of 
viral vectors can be accelerated when using one single vector carrying all four 
reprogramming factors in a polycistronic cassette, instead of transducing the cells with four 
single factor expressing vectors (Somers et al., 2010).  
One drawback of lenti- or retroviral transduction is the random distribution of transgenes in 
the host genome, which could lead to alterations of other genes, for example, tumor 
suppressor genes. Even though excisable or inducible vectors have solved many safety 
issues, iPSCs generated by using integrating viral vectors are still potentially harmful 
especially when they are used for therapeutic application.  
Considering that retro- or lentiviral vectors are potentially harmful many researchers 
engage in finding safer methods for the generation of induced pluripotent stem cells.  
Adenoviral vectors offer another possibility for the delivery of the reprogramming factors 
into the cell, without the risk of genomic integration, by transient expression (Okita et al., 
2008; Stadtfeld et al., 2008b; Zhou and Freed, 2009). Even though adenoviral vectors 
display a safer method, the efficiency of generating iPSCs ranges between 0.0001% and 
0.0018%. In contrast, Fusaki and colleagues recently reprogrammed human fibroblasts using 
F-protein deficient Sendai viral vectors, which transfer the reprogramming genes into the 
host cell and replicate in the form of negative-sense ssRNA in the cytoplasm (Fusaki et al., 
2009). They could show that the efficiency of iPSC induction surpassed even that of retroviral 
transduction. A major drawback of utilizing Sendai virus for reprogramming is the constitutive 
replication of the viral vector, representing a challenge to isolate transgene free clones.  
Since the first iPSCs were generated, many methods of reprogramming were developed. 
Besides the already mentioned viral-integrative and viral non-integrative methods, many non-
viral delivery methods are also now available.  
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PiggyBac transposition, for instance, requires only the piggyBac transposons which carry 
the reprogramming factors (Woltjen et al., 2009). The transposons integrate into already 
existing sites in the genome and are flanked by inverted terminal repeats required for 
transposition. The open-reading frame of piggyBac transposons encodes a transposase, 
which is required to catalyze the insertion. After reprogramming the transgene can be 
removed by a transposase without leaving any residues in the host genome.  
Further reprogramming methods are based on replicating or non-replicating episomal 
vectors. The oriP/Epstein-Barr nuclear antigen-1-based episomal vectors (oriP/EBNA1), 
which were derived from the Epstein-Barr virus, stably replicate extrachromosomally and can 
be subsequently removed from cells in the absence of drug selection (Yu et al., 2009). The 
replication of the oriP/EBNA1 vector is warranted through the cis-acting oriP element and the 
trans-acting EBNA1 gene. On the other hand, these vectors are very large (~12kb) and their 
size results in a very low efficiency of three to six colonies per million cells. In contrast to the 
very large oriP/EBNA1 vectors, minicircle vectors are much smaller (~3kb), non-integrating, 
non-replicating episomes (Jia et al., 2010). Minicircle vectors are supercoiled DNA 
molecules, which lack the origin of replication and the antibiotic resistance gene, that display 
a longer ectopic expression due to lower activation of exogenous DNA-silencing 
mechanisms. 
Additionally, in order to completely avoid plasmids or viral vectors, synthetic mRNAs can 
be directly delivered into the host cells through serial transfection (Warren et al., 2010). Even 
though the mRNA delivery is simple and efficient, its introduction into the host cell results in a 
relatively high gene dosage of reprogramming factors and this entails an oncogenic risk due 
to genomic instability caused by high c-Myc levels.  
Another way to avoid the introduction of exogenous genetic material is the direct delivery 
of proteins. To ensure the transduction into the host cell, proteins were fused with peptides, 
including HIV transactivator of transcription (Tat) or polyarginine (Zhou et al., 2009). A major 
drawback of this reprogramming method is its slow kinetics and the poor efficiency (0.001%). 
Furthermore, due to the extensive purification, it is technically challenging to produce the 
required amounts of protein and therefore difficult to reproduce this experiment.  
Recently Anokye-Danso and colleagues have successfully reprogrammed mouse and 
human somatic cells using lentivirally delivered microRNAs (miRNA-302 cluster) (Anokye-
Danso et al., 2011). In contrast Miyoshi and his group repeatedly transfected cells with a 
cocktail of seven miRNAs (Miyoshi et al., 2011).  
In further reprogramming experiments, small molecules were used to replace one or more 
reprogramming factors or to facilitate the process of dedifferentiation. For example, somatic 
cells could either be reprogrammed with Sox2 and Oct4 when valproic acid was added to the 
reprogramming cocktail (Huangfu et al., 2008), or by adding the inhibitor of Mek/Erk pathway 
together with a glycogen synthase kinase 3 (GSK3) inhibitor, which accelerate the 
reprogramming of mouse cells (Silva and Smith, 2008).   
 
 
1.2.3 Induced pluripotent stem cells for therapeutic purpose 
 
Since the first reprogramming experiments many scientist have become interested in 
using these cells for therapeutic purpose. The iPSC technology offers the possibility of 
generating genetically matched pluripotent cell lines from patients with known, or suspected, 
diseases and to obtain an unlimited numbers of differentiated cell types from all major organs 
of interest. Previously, iPSCs were generated from patients with various diseases, some, but 
not all, exhibit certain disease properties. IPSCs were generated from patients with spinal 
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muscular atrophy (SMA) and during the in vitro differentiation, a loss of motor neurons was 
detected (Ebert et al., 2009). In another study, iPSCs derived from LEOPARD syndrome 
patients were differentiated in vitro into cardiomyocytes that had an enlarged cell body, 
possibly demonstrating the hypertrophic cardiomyopathy involved in this disease (Carvajal-
Vergara et al., 2010). Most of these studies were performed with single patients or used 
hESC lines as controls, and it remains to be determined if these phenotypes are 
reproducible. Furthermore, these studies need to be repeated with large sets of genetically 
matched patients. Nevertheless, these first studies exemplify a proof of principle that disease 
modeling by using iPSC technology is feasible.  
The major goal of using iPSCs for therapeutic purposes is not only to investigate the 
development of a disease but also to find new pathways or drugs that could affect the 
process of the disease. Thus, disease-specific iPSCs in a disease model in vitro would help 
to replace mouse models, which are not always comparable to the human disease 
phenotype. Furthermore, disease-specific iPSCs and differentiated iPSCs that display the 
disease phenotype could be used for high-throughput drug screens in order to find small 
chemicals that either induce the disease phenotype or prevent it. It is of great interest, if a 
disease phenotype can also be achieved from iPSCs for diseases that manifest later in life or 
are caused strongly by environmental factors.  
Another milestone of iPSC technology in regenerative medicine would be the use of 
differentiated iPSCs for cell replacement therapy. To date, cell transplantation for tissue 
repair has just been realized in the haematopoietic system and the skin. Nevertheless, in 
many clinical trials, adult stem cells or even differentiated hESCs are used for transplantation 
therapy. For example, human neural stem cells are transplanted in patients with traumatic 
spinal cord injury, or human embryonic stem cell derived CD15+ Isl-1+ progenitors are 
transplanted in patients with severe heart failure. 
Before the use of iPSC derived lineage-specific cells for cell-based therapies can be taken 
into consideration, some obstacles need to be overcome. Protocols need to be established 
that allow simple and effective differentiation and that yield high amounts of pure 
differentiated cells of a desired lineage. Indeed, fluorescent activated cell sorting, drug 
selection or marker isolation are first steps to overcome this problem. Not only the 
heterogeneity of the differentiated population remains a problem, also the maturation stages 
of generated cells, even in a homogenous population, can vary. Another problem remains 
the introduction of generated cells into the organism. Even though cell-based therapies are 
successful in the haematopoietic system, this may not apply to solid organs. Most solid 
organs display a complex architecture and are well balanced concerning their number of 
cells and the arrangement of cell types. It is unclear if the grafted cells can function in concert 
with the already existing cells. Many studies are still needed to understand the processes 
that determine a cell fate, the developmental processes in a specific cell type and the role of 
a cell within a tissue. 
 
 
1.3 Differentiation of pluripotent cells into keratinocytes in vitro 
 
The current treatment for patients with large burn injuries comprises the in vitro expansion 
of a patient’s own keratinocytes to generate skin replacements. The drawback of this therapy 
is the 3-week delay that is needed to generate an adequate skin replacement. To overcome 
this time period and to minimize the potential risk of infection or dehydration, decellularised 
cadaver skin has been used to cover injured skin temporarily, but access to cadaver skin is 
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limited and there is the risk of immune rejection (Gallico et al., 1984; Guenou et al., 2009). To 
solve the problem of accessibility, new synthetic biomaterials have been developed but up to 
now they cannot replace cadaver skin. 
One major area in the field of regenerative medicine in dermatology is the application of 
stem cells in skin grafts. Stem cells offer the remarkable potential of self-renewal through 
unlimited proliferation and can be differentiated into any cell type of the mammalian body. 
However, the use of pluripotent cells in cell replacement therapies also entails some 
problems that have yet to be resolved. First, cells that can differentiate into any cell type can 
also generate teratomas when injected into an organism. The solution would be to generate 
a 100% homogeneous population of differentiated cells by clonal isolation and expansion in 
culture. Furthermore, it is not clear if the differentiation in vitro would lead to a cell type that is 
identical to the corresponding cell type in the organism (Iuchi et al., 2006).  
Many studies deal with these problems and many efforts have been made to establish 
protocols for the generation of keratinocytes from pluripotent cells. The first studies used 
murine embryonic stem cells (mESCs) (Aberdam, 2004; Coraux et al., 2003; Haase et al., 
2007), later on also human embryonic stem cells (hESCs) (Green et al., 2003; Guenou et al., 
2009; Ji et al., 2006; Metallo et al., 2008) and human induced pluripotent stem cells (hiPSCs) 
(Itoh et al., 2011; Tolar et al., 2011) were used for differentiation into the keratinocyte 
lineage. The differentiation protocols differ from each another based on the culture 
conditions, medium and supplementation as well as coating or supportive feeder layers. 
While some studies used cells grown in monolayers others generated embryoid bodies. 
Embryoid bodies (EBs) are known to recapitulate early embryogenesis and are a favored tool 
for studying mutations that usually induce early death in embryos (Desbaillets et al., 2000; 
Rungarunlert et al., 2009). The drawback of EB formation is that after they have been plated 
to attach, cells grow out and the leading front does not have the same differentiation stage as 
do the cells near the EB. Therefore many differentiation protocols favor 2D culture of the 
cells (Coraux et al., 2003; Guenou et al., 2009; Itoh et al., 2011).  
Another aspect that differs in various protocols is the medium that is used to convert 
pluripotent cells into keratinocytes. Some studies used F12 and Dublecco´s modified Eagle´s 
medium (FAD medium), a commonly used medium for the culture of primary keratinocytes. 
FAD medium contains hydrocortisone to stimulate keratinocyte growth while inhibiting 
fibroblast proliferation but also contains fetal calf serum (FCS) (Green et al., 2003; Guenou et 
al., 2009; Haase et al., 2007). Other protocols prefer ready-to-use media, which are fully 
supplemented with growth promoting agents like the defined keratinocyte serum free medium 
(DKSFM) but without the addition of serum (Itoh et al., 2011; Ji et al., 2006; Metallo et al., 
2008). The addition of supplements for a defined time frame, such as retinoid acid, ascorbic 
acid or BMP4, promotes keratinocyte differentiation. BMP4, for example, was shown to 
permit epithelial differentiation through the inhibition of neural fate, and retinoic acid or 
ascorbic acid which promote the differentiation into keratinocytes (Coraux et al., 2003).  
The most stringent experiment to investigate the functional properties of generated 
keratinocytes is to test their ability to build whole stratified epithelia by grafting them on 
organotypic skin cultures (Aberdam, 2004; Coraux et al., 2003; Guenou et al., 2009; Itoh et 
al., 2011). 
Taken together, many protocols for the differentiation of pluripotent cells into the 
keratinocyte lineage exist, but still no protocol allows for the generation of a 100% pure 
keratinocyte population.  
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1.4 Aim of the project 
 
Patients with large burn injuries are treated with skin replacements, which are generated 
with their own keratinocytes, if possible. However, this method is time consuming, and the 
wounds need to be covered to avoid dehydration and infection. Decellularized cadaver skin 
is used to cover the wounds temporarily, and bridge the time until the skin replacement is 
generated. Nevertheless, the accessibility of cadaver skin is limited and it can provoke an 
immune response in the patient.  
Since the discovery of induced pluripotent stem cells, it was of great interest to use these 
cells for therapeutic purpose. IPSCs display an unlimited source of pluripotent stem cells, 
and if differentiated, an unlimited source of nearly every needed cell type.  
However, in order to use differentiated iPSCs for tissue engineering, the existing in vitro 
protocols need to be optimized.  
In the field of dermatology it is of great interest to establish keratinocyte differentiation 
protocols and use these iPSC-derived keratinocytes for skin replacements. To date, none 
differentiation protocol leads to a 100% pure population of keratinocytes. To optimize the 
protocols, the pathways and mechanisms involved in skin development need to be 
investigated.  
The aim of this project is to find candidates, which are involved in the differentiation of 
pluripotent cells into epithelial cells.  
In detail, hiPSCs will be used as a developmental model and will be differentiated in vitro into 
keratinocytes. It will be investigated, if there are factors, which have an influence on the 
expression of early keratinocyte markers. Further it will be determined if the overexpression 
or the knock-down of these factors, can alter the expression of epithelial markers or the 
number of keratinocyte precursors. 
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2 Material and Methods 
 
2.1 Material 
 
2.1.1 Cell culture media and supplements 
 
Cell culture media and supplements Company 
all-trans Retinoic Acid Sigma Aldrich 
bFGF PromoKine 
BMP4 PromoKine 
Collagen IV Gibco, Life Technologies 
Defined Keratiocyte-serum free Medium (DKSFM) Gibco, Life Technologies 
Dimethyl Sulfoxide (DMSO) Carl Roth 
DMEM GlutaMAX Gibco, Life Technologies 
DMEM/F-12  Gibco, Life Technologies 
Doxycyclin Sigma Aldrich 
Fetal Bovine Serum (FBS) Biochrome AG 
Gelatine from porcine skin, Type A Sigma Aldrich 
Glutamine Sigma Aldrich 
Keratinocyte Growth Medium2 Promocell 
KnockOut DMEM/F12  Gibco, Life Technologies 
KnockOut serum replacement Gibco, Life Technologies 
Matrigel, hES qualified Matrix BD Biosciences  
mFreSR Stemcell Technologies 
mTeSR1 Basal Medium Stemcell Technologies 
Non-essential amino acids Sigma Aldrich 
Normocin InvivoGen 
PBS Gibco, Life Technologies 
Penicillin/Streptomycin Sigma Aldrich 
ROCK-Inhibitor (Y27632) Stemgent, Miltenyi Biotec 
ß-Mercaptoethanol Gibco, Life Technologies 
Trypsin Biochrome AG 
Trypsin/EDTA Sigma Aldrich 
 
 
2.1.2 Cell culture media composition 
 
Medium Composition 
CTK solution H₂O, 0.1 mg/mL collagen IV, 1 mM CaCl₂, 20% KnockOut serum 
replacement, 0.25% trypsin 
Differentiation Medium 
I 
500 µL Defined keratinocyte serum free medium (DKSFM), 1 µM all-
trans retinoic acid, 10 ng/mL BMP4, 50 ng/mL Normocin  
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Medium Composition 
Differentiation Medium 
II 
500 µL Defined keratinocyte serum free medium (DKSFM), 50 ng/mL 
Normocin  
Freezing Medium  FBS, 10% DMSO 
Gelatin solution 0.1% gelatin in H₂O 
hES Medium 
500 mL KnockOut DMEM/F12, 20% KnockOut serum replacement, 
1% glutamine,  1% non-essential amino acids, 1% 
penicillin/streptomycin, 4 ng/mL bFGF, 1 µg/mL doxycyclin, 50 µM ß-
mercaptoethanol 
Matrigel solution  1 aliquot Matrigel™, adjusted to 25 mL mit DMEM/F12 
MEF Medium  500 µL DMEM GlutaMAX, 10% FBS, 1% non-essential amino acids, 1% penicillin/streptomycin, 50 µM ß-mercaptoethanol 
Washing Medium DMEM GlutaMAX, 10% FBS 
 
 
2.1.3 Chemicals 
 
Chemicals Company 
4',6-diamidino-2-phenylindole (DAPI) Roche 
4x Laemmli Sample Buffer BioRad 
Acetic Acid Sigma Aldrich 
Acrylamide Carl Roth 
Ammonium Persulfate (APS) Carl Roth 
Ampicillin Carl Roth 
Braunol®  Braun 
BSA Carl Roth 
CaCl₂ Carl Roth 
Dako Pen Dako, Agilent Technologies 
Eosin Sigma Aldrich 
Ethanol Sigma Aldrich 
Eukitt Sigma Aldrich 
Fluorescence Mounting Medium Dako, Agilent Technologies 
Formalin Sigma Aldrich 
Glycerin Carl Roth 
Hematoxylin Sigma Aldrich 
Isopropanol Carl Roth 
LB-Agar (Lennox) Carl Roth 
LB-Medium (Lennox) Carl Roth 
Lipofectamine RNAiMAX Life Technologies 
Methanol Sigma Aldrich 
Mitomycin C  Carl Roth 
Paraform aldehyde Carl Roth 
Polybrene Sigma Aldrich 
Skim Milk Powder Fluka Analytical™, Sigma Aldrich 
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Chemicals Company 
Sodium Dodecyl Sulfate (SDS) 20% Solution G-Biosciences 
TEMED Carl Roth 
TRIS Hydrochloride  Carl Roth 
Triton-x-100 Carl Roth 
Trizma Base Sigma Aldrich 
Tween 20 Carl Roth 
X-treme Gene Roche 
Xylene Sigma Aldrich 
 
 
2.1.4 Kits 
 
Kits Company 
Amersham™ ECL™ Prime Western Blotting 
Detection Reagent  GE Healthcare 
BCA Protein Assay Kit Pierce, Thermo Scientific 
DNase-Free Dnase Set Qiagen 
EndoFree Plasmid Maxi Kit Qiagen 
RevertAid First Strand cDNA Synthesis Kit  Fermentas, Thermo Scientific 
RNeasy Mini Kit Qiagen 
Subcloning Efficiency™ DH5α™ Competent 
Cells Life Technologies 
FIX&PERM® Cell Permeabilization Kit An Der Grub Bio Research GmbH 
 
 
2.1.5 Buffers and gels 
 
Buffers & gels Composition 
Blocking buffer (HTS) PBS, 3% BSA, 0.05% Triton-x-100 
Blocking buffer (IF)  PBS, 3% BSA, 0.1% Triton-x-100 
Blocking buffer (WB) TBS, 5% skim milk powder, 0.02% tween 20 
FACS buffer  PBS, 2% BSA, 0.2% sodium azide 
Fixation buffer (HTS) PBS, 4% PFA, 0.2% Triton-x-100 
LB agar plates 35 g LB agar powder in 1 L H₂O, autoklaved, 
supplemented with 100 µg/µL ampicillin  
LB medium  20 g LB powder in 1 L H₂O, autoclaved 
Lysis buffer  1 complete Mini tablet, in TBS, 0.1% Triton-x-100 
PBST PBS, 0,1% Triton-x-100 
Running buffer (WB)  H₂O, 0.19 M Glycin, 0.1% SDS, 25 mM Trisma Base 
Separating gel 
2 mL H₂O, 1.65 µL Acrylamide (30%), 1.25 mL Tris (pH 
8.8, 1.5 M), 50 µL SDS (10%), 50 µL APS (10%), 2 µL 
TEMED 
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Buffers & Gels Composition 
Stacking gel 
1.4 mL H₂O, 330 µL Acrylamide (30%), 250 µL Tris (pH 
6.8, 0.5 M), 20 µL SDS (10%), 20 µL APS (10%), 2 mL 
TEMED 
TBS H₂O, 150 mM NaCl, 50 mM Trisma Base, pH adjusted to 7.6  
Transfer buffer (WB) H₂O, 39 M Glycin, 20% Methanol, 0.037% SDS, 48 mM Tris, pH adjusted to 8.3 
Washing buffer (WB) 0.02% Tween 20 in TBS 
 
 
2.1.6 Primary antibodies 
 
Target Host Application Dilution Order No. Company 
Oct3/4 goat  IF 1:250  sc-8628 Santa Cruz 
HIPK4 rabbit  WB 1:500 AP52050PU-N Acris 
Involucrin mouse IF 1:500 I9018 Sigma 
Keratin1 rabbit  IF 1:500 PRB-149P covance 
Keratin14 rabbit  IF 1:250 PRB-155P covance 
Keratin18 mouse IF/FACS 1:50 11416 Progen 
Nanog rabbit  IF 1:500 ab-21624 abcam 
SSEA4 mouse IF 1:500 9094S Cell Signaling 
Tra-1-60 mouse IF 1:500 9094S Cell Signaling 
Tra-1-81 mouse IF 1:500 9094S Cell Signaling 
ß-actin rabbit  WB 1:10,000 5125S Cell signaling 
 
 
2.1.7 Secondary antibodies 
 
Secondary antibody Application Dye Dilution Order No. Company 
α-mouse IgG HRP-
linked Anitbody WB HRP 1:10,000 7076S Cell Signaling 
α-rabbit IgG HRP-
linked Antibody WB HRP 1:10,000 7074S Cell Signaling 
α-goat Alexa Fluor 
488 IF 
Alexa 
Fluor 488 1:500 A11055 Invitrogen 
α-rabbit Alexa Fluor 
488 IF 
Alexa 
Fluor 488 1:500 A11008 Invitrogen 
α-rabbit Alexa Fluor 
594 IF 
Alexa 
Fluor 594 1:500 A11012 
Life 
Technologies 
α-mouse Atto 488  IF Atto 488 1:500 62197 Sigma 
α-mouse Atto 594 IF Atto 594 1:500 76085 Sigma 
α-rabbit Atto 488 IF Atto 488 1:500 5125S Sigma 
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2.1.8 siRNA sequences 
 
siRNA Sequence 
HIPK4 J-004808-09 AGUAUAUGCUCAAGUCGUU 
HIPK4 J-004808-10 AGACGAAGGUGCGCCCAUU 
HIPK4 J-004808-11 AGAAGGAGGCUGCGGGUAU 
HIPK4 J-004808-12 GCAACAACGAGUACGACCA 
Non-targeting Pool #2 (1) UAAGGCUAUGAAGAGAUAC 
Non-targeting Pool #2 (2) AUGUAUUGGCCUGUAUUAG 
Non-targeting Pool #2 (3) AUGAACGUGAAUUGCUCAA 
Non-targeting Pool #2 (4) UGGUUUACAUGUCGACUAA 
 
 
2.1.9 Consumables 
 
Consumables Company 
10 µL filter tips Nerbe Plus 
100 µL filter tips Nerbe Plus 
1000 µL filter tips Nerbe Plus 
10 µL pipette tips Nerbe Plus 
100 µL pipette tips Nerbe Plus 
1250 µL pipette tips Nerbe Plus 
10 mL serological pipette Costar , Corning 
5 mL serological pipette Costar , Corning 
25 mL serological pipette Costar , Corning 
6well plate Cellstar, Greiner Bio-One 
12well plate Cellstar, Greiner Bio-One 
96well microplates (for BCA) Greiner Bio-One 
96well microplates (for QPCR) Nerbe Plus 
384well plate Falcon, Becton Dickinson 
10cm cell culture dish TPP 
10cm Petri dish Falcon, Becton Dickinson 
T75 cell culture flask Cellstar, Greiner Bio-One 
1.5 mL reaction tube Eppendorf 
2 mL reaction tube Eppendorf 
15 mL conical tubes Greiner Bio-One 
50 mL conical tubes Greiner Bio-One 
cryogenic vial Nunc, Thermo Scientific  
1 mL Syringe  Henke Sass Wolf 
50 mL Syringe Terumo 
Needle Neoject, Dispomed 
0.45 µm PVDF filter  Carl Roth  
Disposable Scalpel Feather 
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Consumables Company 
Amersham Hyperfilm™ ECL GE Healthcare 
Chromatography Paper 3mm Whatman 
PVDF Transfer Membrane 0.45 µm pore size Immobilon Millipore 
Latex Medical Examination Gloves Blossom 
Optical Adhesive Film Applied Biosystems, Life Technologies 
Sealing Tape  Costar, Corning 
20 mm ⌀ Glass Cover Slips Assistent, Glaswarenfabrik Hecht 
Glass Object Slides Thermo Scientific 
 
 
2.1.10 Machines and devices 
 
Machines and devices  Product name Company 
Aspiration pump BVC 21 Vacuubrand 
Automated Workstation Biomek FX Beckman Coulter 
Autoradiography Cassette 24X30cm Dr. Goos Suprema  
Bacterial Shaker Innova 4230 New Brunswick Scientific 
Bioimager BP Pathway 855 BD Biosciences 
Biological Safety Cabinet Hera safe Thermo Scientific 
Blotting Devices Mini Trans-Blot Electrophoretic Transfer Cell  Bio Rad 
Cell Incubator Cell Incubator Binder 
Centrifuge 5418R Eppendorf 
Centrifuge 5810R Eppendorf 
Centrifuge Heraeus Multifuge X3 FR Thermo Scientific 
Computer Precision T3500 Dell 
Digital Camera ORCA-ER Hamamatsu 
Flourescence Microscope Eclipse Ti Nikon 
Flow Cytometer FACSCanto II BD Biosciences 
Freezer Premium Liebherr 
Freezing Container Freezing Container Qualilab  
Fridge Premium Liebherr 
Hemocytometer Neubauer 0.1 mm Assistent, Glaswarenfabrik Hecht 
Inverted Microscope Eclipse TS100 Nikon 
Laptop Latitude E6510 Dell 
Liquid Nitrogen Tank Chronos Messer Griesheim 
Microscope  Leica DMLS Leica 
Microscope Camera EC3 Leica Leica 
Microscope Camera DS-Qi1Mc Nikon 
Microtome RM 2065 Leica 
Orbital Shaker Polymax 2040 Heidolph 
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Machines and devices  Product name Company 
Power Supply Power Pac 300 Bio Rad 
Reagent Dispenser Multidrop Combi  Thermo Scientific 
Real-time QPCR cycler 7500 Real-Time PCR System Applied Biosystems 
Roller Mixer RM5-30V CAT 
SDS Gelelektrophoresis 
Devices Mini-PROTEAN Tetra Cell Bio Rad 
Spectralphotometer Spectralfluor Plus Tecan 
Spectrophotometer Nanodrop ND-100 PeqLab 
Thermomixer  Thermomixer compact Eppendorf 
Tissue Processor TP1020 Leica 
Vortex Mixer  Vortex Mixer  Heidolph 
 
 
2.1.11 Material for Microarray 
 
Chemicals and solutions Company 
Illumina Total-Prep RNA Amplification Kit Life Technologies 
Biotin-16-UTP Roche Applied Bioscience 
GEX-HCB Buffer Illumina Inc. 
High Temp Wash Buffer Illumina Inc. 
E1BC Buffer Illumina Inc. 
Blocking Solution (1% Blocker Casein in PBS 
Hammarsten Grade)  Pierce Biotechnology 
Cy3-Streptavidin Amersham Bioscience 
 
Machines and devices Company 
2100 Bioanalyzer  Agilent 
iScan Array Scanner Illumina Inc. 
Human Sentrix 12 Bead Chip Arrays Illumina Inc. 
 
 
2.1.12 Software 
 
Software Company/developer 
7500 Software v2.0.5  Applied Biosystems®, Life Technologies  
Bioconductor/R open development project 
cellHTS2 M.Boutros, L.Bras, W.Huber 
CellProfiler Broad Institute 
Chipster CSC - IT Center for Science 
GraphPad Prism 6 GraphPad Software 
ImageJ W.Rasband, National Institutes of Health 
Megallan™ Data Analysis Software Tecan 
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Software Company/developer 
Microsoft Office Excel 2007 Microsoft 
Microsoft Office PowerPoint 2007 Microsoft 
Microsoft Office Word 2007 Microsoft 
NIS Elements Nikon 
 
 
2.1.13 Plasmids 
 
Plasmid Label Received from  
Reprogramming 
vectors 
TetO human 
STEMCCA floxed  Group of K.Hochedlinger, Ref.: Sommer 2009 
Transactivator FUdeltaGW-rtTA  Group of K.Hochedlinger, Ref.: Sommer 2009 
Packaging plasmid pCMV-dR8.91  Group of K.Hochedlinger, Ref.: Sommer 2009 
Envelope plasmid pCMV-VSV-G  Group of K.Hochedlinger, Ref.: Sommer 2009 
Empty vector pLenti CMV GFP Puro  Addgene, Plasmid 17448, Eric Campeau 
HIPK4 expression 
vector pCW45-HIPK4  
The Dana-Farber/Harvard Cancer Center DNA 
Resource Core; CloneID: HsCD00299059 
 
 
2.1.13.1 TetO human STEMCCA floxed (reprogramming cassette) 
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2.1.13.2 FUdeltaGW-rtTA (transactivator) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.1.13.3 pCMV-dR8.91 (packaging plasmid, ∆8.9) 
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2.1.13.4 pCMV-VSV-G (packaging plasmid, VSV-G) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.1.13.5 pLenti CMV GFP Puro (empty control vector) 
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2.1.13.6 pCW45-HIPK4 (HIPK4 expression vector) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.1.14 QPCR Primer sequences 
 
Target Forward Primer 5`-3` Reverse Primer 3´-5´ 
18S GAGGATGAGGTGGAACGTGT TCTTCAGTCGCTCCAGGTCT 
GAPDH GAAGGTGAAGGTCGGAGTC GAAGATGGTGATGGGATTTC 
HIPK4 GGTCAAGGTGATTGACTTCGG GGTTGCGCTTGAAGAAGTGG 
Involucrin TGTGAGTCTGGTTGACAGTAGC ATTCTTGCTCAGGCAGTCCC 
Keratin 14 AGGAGATCGCCACCTACCGCC AGGAGGTCACATCTCTGGATGACTG 
Keratin 18 GAGTATGAGGCCCTGCTGAACATCA GCGGGTGGTGGTCTTTTGGAT 
Keratin 5 ATCTCTGAGATGAACCGGATGATC CAGATTGGCGCACTGTTTCTT 
Keratin 8 GATCGCCACCTACAGGAAGCT ACTCATGTTCTGCATCCCAGACT 
Lin28 TGAGGCAGTGGAGTTCACCT CTTGCATTCCTTGGCATGAT 
Nanog AGGAAGACAAGGTCCCGGTCAAG TGCTGAGGCCTTCTGCGTCAC 
P63 TTCTTAGCGAGGTTGGGCTG GATCGCATGTCGAAATTGCTC 
REX1 TTGGAGTGCAATGGTGTGAT TCTGTTCACACAGGCTCCAG 
Sox2 GTGAGGGCCGGACAGCGAAC GCGTACCGGGTTTTCTCCATGCT 
TERT GCGTTTGGTGGATGATTTCT CAGGGCCTCGTCTTCTACAG 
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2.2 Methods 
 
2.2.1 Plasmid preparation  
 
2.2.1.1 Transformation of bacteria  
 
Competent DH5α bacteria were used as an amplifying system to obtain large quantities of 
DNA plasmids. Competent bacteria are cells that were treated with CaCl2 in order to increase 
the permeability of their cell membrane to DNA. For the amplification of naked DNA, DNA 
plasmids need to be introduced into the bacteria cell, which then makes multiple copies of 
the DNA. 
Frozen stocks of competent E. coli DH5α were thawed on ice. 1 µg DNA was added to the 
thawed bacteria cells and incubated for 15 min. The cells were then heat-shocked for 2-3 min 
at 42 °C. The bacteria were then placed back on ice. Then 1 mL LB Medium was added to 
the cells and they were incubated for 30 min at 37 °C while shaking. The transformed 
bacteria were then plated on agar plates, which contain the appropriate antibiotic and 
incubated over night at 37 °C.  
 
 
2.2.1.2 Preparation of glycerolstocks 
 
Transformed bacteria colonies were picked from agar plates with a pipette tip and 
transferred into 5 mL LB medium containing the appropriate antibiotics. These cultures were 
inoculated over night at 37 °C vigorously shaking. The next day, 500 µL bacterial culture was 
mixed with 500 µL glycerol and frozen at -80 °C. Glycerolstocks of every plasmid were 
prepared for long term storage. 
 
 
2.2.1.3 Endo-free plasmid preparation and purification  
 
Transformed bacteria grown in colonies on agar plates were picked and transferred into 
LB medium. Bacteria were incubated over night at 37 °C vigorously shaking. The next day 
these pre-cultures were used to inoculate large cultures. The plasmids from 200 mL over-
night cultures were isolated using the EndoFree Plasmid Maxi Kit from Qiagen, according to 
the manufacturer’s protocol “Plasmid or Cosmid DNA Purification using EndoFree Plasmid 
Maxi Kit”. 
At the last step, the plasmid pellet was resuspended in 30 µL endotoxin-free Buffer TE or 
endotoxin-free water. The concentration of the plasmid was determined using a photometer. 
The concentration was adjusted to 1 µg/µL for every plasmid. 
 
 
2.2.2 Cell culture methods 
 
2.2.2.1 Culture of 293T HEK cells and virus production 
 
293T HEK cells were cultured in MEF medium (DMEM GlutaMAXTM containing 10% FBS, 
1x non-essential amino acids, 1% penicillin/streptomycin and 50 µM ß-mercaptoethanol) in 
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T75 cell culture flasks and routinely passaged 2-3 times a week. For passaging the cells, 
medium was aspirated and cells were washed twice with 10 mL PBS. Trypsin/EDTA was 
added to the cells just enough to cover the entire surface (~3 mL) and incubated at 37 °C 
until the cells started to detach. Trypsin/EDTA activity was inhibited by adding 5 mL washing 
buffer (DMEM GlutaMAX™ supplemented with 10% FBS), cells were rinsed, aspirated and 
transferred into a 15 mL conical tube. The cell suspension was then centrifuged for 5 min at 
1200 rpm. The supernatant was discarded, the cell pellet was resuspended in 5 mL fresh 
MEF medium and 1/10 of the cell suspension (500 µL) was transferred into a new cell culture 
flask with 10 mL MEF medium. Cells were cultured at 37 °C and 5% CO2. 
293T HEK cells were used as packaging cells, to produce lentiviral particles. For this 
purpose, the cells were transfected with an envelope plasmid, a packaging plasmid and a 
vector that contains the gene of interest. The envelope and packaging vectors provide all 
required proteins that are needed to produce the viral particles. A list of plasmids used for 
viral production can be found in the “Material” part (2.1.13 Plasmids).  
For the production of lentiviral particles, 293T HEK cells were cultured in MEF medium 
and grown in T75 cell culture flasks (75 cm2). On the day of transfection the cells should be 
50-70% confluent. Before transfection, the medium was changed to MEF medium without 
antibiotics, since antibiotics can decrease the transfection efficiency. DMEM GlutaMAX™ 
and transfection reagent (X-tremeGENE9, Roche) were preheated to room temperature. For 
one flask 770 µL DMEM GlutaMAX™ was applied to a 1.5 mL reaction tube and 50 µL 
transfection reagent was added. The solution was mixed by pipetting and incubated for 5 min 
at room temperature. The DNA was added at following ratios: 1x VSV-G (envelope plasmid), 
1.5x ∆8.9 (packaging plasmid) and 2x plasmid of interest. The transfection-mix was then 
incubated at room temperature for 30 min. After the incubation time the transfection-mix was 
added to the cells. The medium was discarded after 12-24h and fresh MEF medium was 
added to the cells. Medium containing the virus particles was harvested after another 12, 24, 
and 36 hours and stored at 4 °C. After the last harvest the virus-containing medium was 
filtered, using 0.45 µm PVDF filters. The filtered virus particle-containing supernatant was 
concentrated by centrifugation using an ultracentrifuge at 40.000 rpm at 4 °C for 2h. The 
supernatant was discarded, 100 µL PBS was applied directly on the virus pellet and 
incubated over night at 4 °C. The next day the concentrated virus was aliquoted and stored 
at -80 °C. 
The Virus production was performed in a S2 laboratory, according to the safety 
instructions.  
 
 
2.2.2.2 Coating of cell culture plates 
 
2.2.2.2.1 Thin Matrigel™ coating 
 
Human ES-cell qualified Matrigel™ was thawed on ice at 4 °C over night. For aliquot 
preparation pipette tips and 1.5 mL reaction tubes were kept cool. Thawed Matrigel™ 
solution was aliquoted in amounts according to manufacturer’s instructions specifically for 
every lot and stored at -20 °C. For thin Matrigel™ coating aliquots were thawed on ice and 
pipette tips and cell culture dishes were pre-cooled. One Matrigel™ aliquot was diluted up to 
25 mL with ice-cold DMEM/F12. One well of a 6-well plate was rinsed with 1 mL Matrigel™-
solution (1 mL per ~10 cm2). Coated plates were incubated for 1 hour at room temperature. 
After incubation time plates could be either directly used or were stored up to one week at 
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4 °C. Prior to use Matrigel™ solution was aspirated and culture plates were rinsed with 
DMEM/F12 in order to remove surplus Matrigel™. 
 
 
2.2.2.2.2 Gelatin coating 
 
For coating cell culture plates, 0.1% gelatin solution was added (~1 mL per 10 cm2) and 
incubated at room temperature for at least 30 min. After incubation, gelatin solution was 
aspirated and plates were rinsed with PBS in order to remove surplus gelatin. The plates 
were then ready-to-use.  
 
 
2.2.2.3 Isolation of primary human fibroblasts and keratinocytes from skin biopsies 
 
Freshly obtained skin biopsies were transferred into MEF medium and were stored not 
longer than 24h at 4 °C. The biopsy was transferred into PBS and then on a petri dish 
without medium. Adipose tissue was removed from the biopsy and cut into small pieces. The 
pieces were placed in a tissue culture dish containing MEF medium, just enough medium 
was added that the pieces were completely covered but not floating. The remaining biopsy 
was cut into small squares, approximately 0.5x0.5 cm in size. These tissue squares were 
transferred into 35 mm cell culture dishes containing 0.25% trypsin in PBS and incubated 
overnight at 4 °C. The next day, the epidermis was carefully removed from the dermal part 
with forceps and transferred into fresh trypsin. The dermal part was transferred into a petri 
dish. The tissue was then thoroughly chopped with scalpels in order to dissociate it. These 
tissue fragments were then resuspended in MEF medium, plated in a tissue culture dish and 
kept at 37 °C and 5% CO2 until fibroblasts grew out. The epidermal pieces in trypsin were 
centrifuged at 1200 rpm for 5 min. The supernatant was aspirated and the pellet was 
resuspended in Keratinocyte Growth Medium (KGM supplemented with 10% FBS and 1% 
penicillin/streptomycin). The suspension was plated on cell culture dishes and kept at 37 °C 
and 5% CO2 until keratinocytes grew out. After 4-5 days medium was added carefully to the 
cultures and changed for the first time after 10 days. The medium for keratinocytes was 
replaced by KGM with lower FBS (1%) concentration. Fibroblasts from adipose and dermal 
tissue were cultured described as below (section “2.2.2.6 Culture and cryopreservation of 
mouse and human primary fibroblasts”).   
 
 
2.2.2.4 Isolation of mouse embryonic fibroblasts 
 
14 days after fertilization pregnant mice were sacrificed followed by an abdominal incision. 
The uterus was excised, the embryos were separated from the amniotic membranes and 
transferred into a disinfection solution (Braunol®). The embryos were then washed with PBS 
and the head and the fetal liver were removed using a scalpel. In order to dissociate the 
tissue, the embryos were placed in a petri dish, bedewed with Trypsin/EDTA and thoroughly 
chopped with scalpels. The suspension was transferred into a MEF medium containing 
conical tube. Up and down pipetting led to further dissociation of the tissue. The cells were 
then seeded on gelatin coated (paragraph “2.2.2.2.2 Gelatin coating”) cell culture plates and 
kept at 37 °C and 5% CO2 without moving them for 5 days. Fresh medium was added at day 
5 and could be changed when the cells attached to the culture plate. When the cells reached 
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100% confluency they were either frozen (paragraph “2.2.2.6 Culture and cryopreservation of 
mouse and human fibroblasts”) or treated with mitomycin c for feeder preparation (see 
paragraph “Preparation of feeder cells from mouse embryonic fibroblasts”). 
 
 
2.2.2.5 Preparation of feeder cells from mouse embryonic fibroblasts 
 
Primary MEFs were expanded in a 75 cm2 cell culture flask in MEF medium until reaching 
90% confluency. The MEFs were rinsed twice with PBS and subsequently incubated with 
DMEM GlutaMAXTM supplemented with 10% FBS and 8 µg/mL mitomycin c for 5 h at 37 °C. 
After the incubation time the cells were washed two times with PBS with magnesium and 
calcium and two times with PBS without magnesium and calcium. The mitomycin c treated 
cells withdraw from the cell cycle and are postmitotic. The feeder cells were then either 
seeded directly for use with a density of 4000 cells/cm2 or cryopreserved for later use (see 
next section). 
 
 
2.2.2.6 Culture and cryopreservation of mouse and human primary fibroblasts  
 
Mouse and human fibroblasts were routinely cultured in MEF medium. Before reaching 
100% confluency cells were passaged. For this purpose, cells were washed twice with PBS 
and Trypsin/EDTA was added. After 5 min of incubation at 37 °C washing buffer was added 
and detached cells were rinsed. The cell suspension was transferred into a conical tube and 
centrifuged for 5 min at 1200 rpm. The supernatant was discarded and the pellet was 
resuspended in fresh MEF medium. The cells were then seeded on gelatin coated plates in 
MEF medium. For cryopreservation, 1 mL (1*106 cells) of cell suspension was transferred 
into cryogenic vials and 1 mL freezing medium (FBS supplemented with 10% dimethyl 
sulfoxide (DMSO)). The cryogenic vials were then placed in isopropyl alcohol filled freezing 
containers and cooled down to -80 °C. The next day the cells were transferred into a liquid 
nitrogen tank for long term storage.  
For thawing mouse and human primary fibroblasts, frozen cryogenic vials were thawed in 
a water bath at 37 °C. Before the cells were completely thawed, fresh MEF medium was 
added. The cell suspension was transferred into a conical tube containing 5 mL MEF 
medium and centrifuged at 1200 rpm for 5 min. The supernatant was aspirated and the pellet 
was dissociated in MEF medium. The cells were then seeded on gelatin-coated plates in 
MEF medium and kept in a cell incubator at 37 °C and 5% CO2.  
 
 
2.2.2.7 Culture and cryopreservation of human primary keratinocytes 
 
Primary keratinocytes were routinely passaged once after isolation, followed by 
cryopreservation. In culture, primary keratinocytes differentiate rapidly into terminally 
differentiated cells, thus isolated cells were cryo-preserved at passage 1.  
Isolated and attached primary keratinocytes were grown in Keratinocyte Growth Medium 
(KGM supplemented with 1% FBS and 1% penicillin/streptomycin. When reaching a 
confluency of 70-80% primary keratinocytes were passaged. Cells were rinsed with PBS 
twice and afterwards Trypsin/EDTA was added. After incubation of 5-10 min at 37 °C 
washing medium was added, the cells were rinsed and transferred into a conical tube. The 
Methods  Material and Methods 
 
54 
cells were then centrifuged for 5 min at 1200 rpm. The cell pellet was resuspended in fresh 
KGM and plated at a dilution ratio of 1:3 in cell culture dishes. For cryopreservation, 1*106 
cells in 1 mL medium were transferred into a cryogenic vial and 1 mL freezing medium was 
added. The vial was placed in a freezing container and kept at -80 °C overnight. The next 
day vials were placed in a liquid nitrogen tank for long term storage.   
 
 
2.2.3 Generation and culture of human induced pluripotent stem cells 
 
2.2.3.1 Generation of human induced pluripotent stem cells 
 
For the generation of human induced pluripotent stem cells (hiPSCs) primary human 
fibroblasts were co-transduced with the StemCCA plasmid, which contains the four 
reprogramming transgenes Oct4, Klf4, Sox2 and c-Myc, and the reverse tetracycline 
dependent transactivator M2. 
Fibroblasts isolated from healthy donor biopsies were cultured on gelatin coated plates 
(see section “2.2.2.2.2 Gelatin coating”) for one passage in MEF medium. The fibroblasts 
were then seeded on gelatin coated 6well plates with a density of 5000 cells/well. For 
transduction with lentiviral particles, fibroblasts were rinsed with PBS and 2 mL MEF medium 
was added followed by 5 µL of M2 and 5 µL of StemCCA concentrated virus. To improve 
viral transduction 1 mg/mL polybrene was supplemented to the medium. Polybrene (1,5-
dimethyl-1,5-diazaundecamethylene polymethobromide) is positively charged and 
neutralizes the charge repulsion between the viral particle and the cell surface, which 
facilitates the transduction.  
After 24 h, the medium was aspirated and cells were rinsed with PBS, followed by another 
round of transduction. The next day, cells were washed twice with PBS and a 1:1 mixture of 
MEF medium with hES medium (KnockOutTM DMEM-F12 supplemented with 20% 
KnockOutTM serum replacement, 1x non-essential amino acids, 1% glutamine, 1% 
penicillin/streptomycin, 50 µM ß-mercaptoethanol and 4 ng/mL bFGF) was added to the 
cells. To induce the transgene expression the medium was supplemented with 1 µg/mL 
doxycycline. The transduced cells were cultured in the mix-medium for 1 week and 
afterwards in hES medium supplemented with 1 µg/mL doxycycline for the activation of M2. 
After four to six weeks appearing hiPSC colonies were picked manually and transferred onto 
mitomycin c treated feeder cells (see paragraph “2.2.2.5 Preparation of feeder cells from 
mouse embryonic fibroblasts”). The cells were then cultured for about two weeks until 
reaching a stable state, thenceforth doxycycline was withdrawn. The hiPSCs where then 
picked and transferred onto thin MatrigelTM coated cell culture plates and cultured in 
mTeSRTM1 (supplemented with 50 µg/mL Normocin™).  
 
 
2.2.3.2 Culture of human induced pluripotent stem cells  
 
Stable clones of hiPSCs were cultured in feeder-free conditions in thin MatrigelTM coated 
cell culture flasks (see section “2.2.2.2.1 Thin Matrigel™ coating”) in mTeSRTM1 
(supplemented with 50 µg/mL Normocin™). Every second day, medium was changed and 
colonies were rinsed with DMEM/F12 to remove dead cells. Before changing the medium, 
cultures were examined under an inverted microscope and differentiating cells or overgrown 
areas were removed mechanically using a 100 µL pipette tip. Before reaching confluency, 
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hiPSC colonies were passaged every 5-7 days. Cells were rinsed with DMEM/F12 and 
incubated for 7 min in CTK solution at 37 °C. Cultures were then washed twice with 
DMEM/F12 and 1 mL mTeSRTM1 was added to the cells. Colonies were disrupted 
mechanically into smaller clumps by scratching with a pipette tip. Floating small cell clumps 
were aspirated carefully with a 5 mL pipette to avoid the complete dissociation into single 
cells. Cell clumps were then transferred into new thin MatrigelTM coated 6well plates and 
medium was adjusted to a volume of 2 mL/well. The next day, 1 mL mTeSRTM1 medium was 
added per well of a 6well plate. HiPSCs were maintained at 37 °C and 5% CO2. 
 
 
2.2.3.3 Cryopreservation and thawing of hiPSCs grown on MatrigelTM 
 
Cells were cultured routinely on thin MatrigelTM coated 6well plates in mTeSRTM1 medium. 
For cryopreservation, cells were first rinsed twice with DMEM/F12 and then detached by 
adding 800 µL CTK solution per well and incubating for 7 min at 37 °C. The CTK solution 
was aspirated carefully, cells were washed twice with DMEM/F12, and 1 mL of mFreSRTM 
medium was added to the cells. Cell colonies were then scratched mechanically using a 
pipette tip, in order to detach whole colonies of hiPSCs. The cell clump suspension was then 
transferred into cryogenic vials. To achieve a mild cryopreservation, cryogenic vials were 
placed in freezing containers filled with isopropyl alcohol and stored at -80 °C over night. The 
next day, vials were transferred into liquid nitrogen containers until further use.  
To thaw cryopreserved hiPSCs, cryogenic vials were removed from liquid nitrogen and 
transferred into a water bath at 37 °C. The cryogenic vials were removed from the water 
bath, just before the cells were completely thawed. 1 mL of pre-warmed mTeSRTM1 medium 
was added to the cells and the suspension was spun down for 5 min at 900 rpm. After 
aspiration of the supernatant, 2 mL mTeSRTM1 medium was added and the cells were 
carefully resuspended, without disrupting the clumps. HiPSCs were then plated on freshly 
MatrigelTM coated 6well plates. The next day 1 mL mTeSRTM1 medium was added to the 
cells. The cells were cultured routinely as described above and kept at 37 °C and 5% CO2. 
 
 
2.2.4 Epithelial differentiation protocol 
 
HiPSCs were cultured on Matrigel™ coated 6well plates, as previously mentioned. 1 h 
before seeding the cells for differentiation, ROCK-inhibitor (10 µM) was added to the cells to 
prevent single cell provoked apoptosis. HiPSCs were washed twice with 2 mL DMEM/F12 
per well, 800 µL CTK solution was added, followed by 7-9 min incubation at 37 °C. The CTK 
solution was aspirated when the edges of the colonies started to detach and the cells were 
then washed twice very carefully with DMEM/F12. Then Trypsin/EDTA was added and 
incubated for 3 min at 37 °C. Afterwards, mTeSR™1 medium containing ROCK-inhibitor was 
added, cells were rinsed carefully and transferred into a conical 15 mL tube. The cell solution 
was centrifuged at 900 rpm for 5 min. The supernatant was aspirated and the cell pellet was 
resuspended in Differentiation Medium I (Defined Keratinocyte-Serum Free Medium 
containing 1 µM all-trans retinoic acid, 10 ng/mL BMP4 and 50 µg/mL Normocin). The cell 
number was determined using a hemocytometer and the cell suspension was adjusted to 
1*106 cells per 1 mL. The cells were seeded on Matrigel™ coated plates and dishes at the 
following density: 150.000 cells per well of a 12well plate (or glass coverslip), 350.000 cells 
per well of a 6well plate, 2.2*106cells per 10 cm dish. The next day, medium was changed to 
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fresh differentiation medium and cells were washed carefully with DMEM/F12. On day 4, 
medium was aspirated, cells were washed twice with DMEM/F12 and fresh Differentiation 
Medium II (DKSFM supplemented with 50 µg/mL Normocin) was added. Cells were 
harvested every 5 days for RNA or protein isolation, or were fixed for further stainings. The 
differentiation was stopped either on day 10 or on day 30.  
 
 
2.2.5 High-throughput siRNA screen 
 
The knock-down of genes using siRNA is a commonly and frequently used method to 
determine gene functions. In this experiment a kinome siRNA library (siGenome, 
Dharmacon) was used to knock down certain kinases during the differentiation of hiPSCs 
into the epithelial lineage. After 10 days of differentiation, the cells were stained for 
immunofluorescence against keratin 18 (K18), which is a marker for simple or embryonic 
epithelia. 
 
 
2.2.5.1 Seeding and transfecting cells 
a384well plates were coated with 10 µL Matrigel™ (see “Thin Matrigel™ coating”) per well 
384well plates were coated with 10 µL Matrigel™ (see “Thin Matrigel™ coating”) per well 
using a reagent dispenser (Multidrop™ Reagent Dispenser, Thermo Scientific). The plates 
were sealed with silver foil and stored at 4 °C until use.  
SiRNAs (siGenome, Dharmacon) which were used to transfect the cells, were provided in 
three stock plates in a concentration of 250 nM in a pool of four single siRNAs. After 
aspirating the Matrigel™ solution, 5 µL of each siRNA was pipetted into the corresponding 
plate using an automated workstation (Biomek® FX, Beckman Coulter), resulting in three 
plates per run. Conditions maintaining pluripotency served as negative control (wells D2 to 
M2) and conditions promoting differentiation served as positive control (wells D3 to M3).  
Transfection was performed by mixing 4.95 µL DMEM/F12 with 0.05 µL transfection 
reagent (Lipofectamine®RNAiMAX Transfection Reagent) (amount for 1 well), incubating for 
10 min and adding to the wells using a reagent dispenser. After another 20 min of incubation 
the plates were ready for seeding the cells. 
HiPSCs were dissociated as previously described (see paragraph “2.2.4 Epithelial 
differentiation protocol”). Two cell suspensions with different media and cell number were 
prepared: 
 
1) hiPSCs in Differentiation Medium I, 100.000 cells/mL 
a. hiPSCs in mTeSR™1 (supplemented with 50 µg/mL Normocin), 
50.000 cells/mL 
 
40 µL of the cell suspensions were added to the plates using a reagent dispenser. The 
plates were shortly spun down and kept at 37 °C and 5% CO2. On culture day 5 additional 
50 µL medium was added. Instead of Differentiation Medium I, Differentiation Medium II was 
added to the cells. The cells were cultured until day 10. 
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2.2.5.2 Fixation and immunofluorescence staining 
 
Fixation, blocking and fluorescence staining were performed using an automated 
workstation.  
After 10 days of differentiation, medium was aspirated and 50 µL of fixation buffer (1xPBS 
with 4% PFA and 0.2% Triton-x-100) for high-throughput screens (HTS) was pipetted into 
each well and incubated for 30 min at RT. The fixation buffer (HTS) was aspirated and the 
cells were washed with 50 µL PBS twice. Then 50 µL blocking buffer (1xPBS with 3%BSA 
and 0.05% Triton-x-100) (for HTS) was added and incubated for 45 min at RT. The K18 
primary antibody dilution was prepared and pipetted into a 384-deepwell plate using a 
multichannel pipette. This plate was then placed into the automated workstation as a 
reservoir plate. After aspirating the blocking buffer, the cells were washed with PBS and 
10 µL K18 primary antibody diluted in blocking buffer was pipetted from the 384-deepwell 
plate into the wells. It is to mention that with the automated workstation not the whole liquid in 
the well can be aspirated, there is a residual amount of about 10 µL remaining. These 10 µL 
residual amount must be taken into consideration when calculating the dilution of the primary 
antibody. Thus the concentration must be doubled (1:25 for K18). 
The plates were sealed with silver foil and incubated over night at 4 °C. The next day, the 
antibody solution was aspirated and the cells were washed three times with 50 µL PBS. The 
secondary antibody (α-mouse Atto 594) was diluted with PBS, just as for the primary 
antibody the double concentration was used (1:250). In addition, 4´,6-diamidino-2-
phenylindole (DAPI, 1 ng/mL) was added to the dilution, for nuclear staining. The dilution was 
then pipetted into a 384-deepwell plate, which was placed in the automated workstation. 
There the dilution was added to each well and incubated for 1 h at RT under exclusion of 
light. After incubation the staining solution was aspirated and the cells were washed four 
times with PBS. As a last step 20 µL PBS were pipetted into the wells, the plates were 
sealed with silver foil and stored at 4 °C until imaging.  
 
 
2.2.5.3 Automated imaging and data analysis 
 
Imaging was performed using an automated BD Pathway 855 Bioimaging System (Becton 
Dickinson) with a 20x objective (NA: 0.75) and a Hamamatsu digital camera (Orca-ER). Per 
well 25 fields were imaged for both filters, Hoechst (nuclei staining) and FITC (K18 staining).  
Images were analyzed using the Cellprofiler image analysis software Version 2.0. Object 
selection was based on adaptive intensity and fixed size thresholds for every single object. 
The segmentation of objects was optimized in order to reach the best resolution even in 
dense cell clusters. For data analysis, parent objects were segmented in channel 1 
(Hoechst), and in channel 2 (FITC) the mean intensity of child objects was measured. Based 
on the mean intensity of every nucleus, nuclei were categorized into a K18-positive and K18-
negative cell, according to the manually set mean intensity threshold. The values of K18-
positive cells were used for further analysis. To prevent strong viability effects, wells with less 
than 1000 cells were excluded from the analysis.  
For data analysis, the cellHTS2 software was used. The fraction of K18-positive cells per 
well were normalized per assay plate and the z-scores were calculated using the R package 
cellHTS2. The correlation between the data of replicates was estimated using the Spearman 
rank correlation coefficient.  
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2.2.6 Transfection of hiPSCs with siRNAs 
 
To examine the role of HIPK4 during the early differentiation of hiPSCs into keratinocyte 
lineage, HIPK4 was knocked down using a set of four siRNAs. The cells were transfected on 
day 1 after seeding, and differentiated for 10 days.  
The cells were seeded on Matrigel™ coated dishes as described before (see 
Differentiation of hiPSCs) in Differentiation Medium I. For transfection with siRNAs, 
transfection reagent was added to DMEM/F12 and incubated for 10 min (for exact amounts, 
see information below). After incubation time, either the set of four siRNAs against HIPK4 or 
the non-targeting siControl were added and incubated for 20 min at RT. Then the 
transfection mix was added to the cells. The final siRNA concentration amounts to 25 nM. 
After 2 days, medium was aspirated, the cells were washed twice with PBS and fresh 
Differentiation Medium I was added. At day 4 of differentiation, the medium was aspirated, 
the cells washed again and cultured in Differentiation Medium II. The medium was changed 
every 2 days and the cells were harvested either on day 5 and day 10 or only on day 10.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.2.7 Molecular biological methods 
 
2.2.7.1 RNA isolation  
 
For total RNA isolation from cultured cells the RNeasy Mini Kit from Qiagen was used and 
performed according to manufacturer’s protocol. Furthermore, an on-column DNase 
digestion was carried out using the DNase-Free DNase Set (Qiagen) in order to eliminate 
contaminating DNA.  
In the last step, the RNA was eluted using 30 µL RNAse-free water. The concentration of 
eluted RNA was measured with a photometer and RNA samples were stored at -80 °C.  
 
 
2.2.7.2 Reverse transcriptase-polymerase chain reaction 
 
The reverse transcriptase-polymerase chain reaction (RT-PCR) was performed in order to 
transcribe RNA into cDNA. Therefore, the RevertAid First Strand cDNA Synthesis Kit 
(Thermo Scientific) was used and performed as directed in the “First Strand cDNA Synthesis” 
protocol. In every experiment 500 µg RNA were reverse transcribed .The transcribed cDNA 
was adjusted with nuclease-free water up to 200 µL and used for real-time PCR analysis. 
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2.2.7.3 Real-time polymerase chain reaction 
 
The real-time polymerase chain reaction (QPCR) method allows quantifying the 
expression level of genes. For the QPCR 2.5 µL cDNA (preparation described in section 
“2.2.7.2 The Reverse Transcriptase-Polymerase Chain Reaction”) was pipetted in each well 
of a 96-well plate. Per well following solutions were added 0.15 µL primer-solution (mix of 
forward and reverse primer, concentration: 10 µM), 5 µL SYBR®Green and 2.35 µL water. 
The plate was sealed with a foil and spun down.  
The experiment was performed using the Applied Biosystems® 75000 Real-Time PCR 
System. For all experiments the Quantitation – Comparative CT (∆∆CT) program type was 
used with following run methods: 
 
 holding stage  50 °C for 2 min 
    95 °C for 10 min 
 cycling stage  95 °C for 15 sec  
    60 °C for 1 min cycling stage repeated for 40 cycles 
 melt curve stage  95 °C for 15 sec 
    60 °C for 1 min 
    95 °C for 30 sec 
    60 °C for 15 sec 
 
The data were analyzed using the 7500 Software v2.0.5 (Applied Biosystems®). 
 
 
2.2.7.4 Genome wide expression profiling using Illumina BeadChips® 
 
Genome wide expression profiling using Illumina BeadChip® HumanHT-12 v4 was 
performed at the Genomics and Proteomics Core Facility at the DKFZ. With this method it is 
possible to analyze the expression level of 31,000 annotated genes (48,107 genes in total) 
on one chip in a high-throughput process. For this purpose, RNA was isolated (see 
paragraph ”2.2.7.1 RNA isolation”) from normal human keratinocytes (NHK), hiPSCs and 
cells after 10 days of differentiation. From all samples (respectively three biological replicates 
per sample) 1 µg RNA was used for the profiling. The following steps were carried out by the 
members of the Core facility. 
In order to determine the quality of the provided RNA, the samples were checked on an 
Agilent 2100 Bioanalyzer (Agilent Technologies) using the total RNA Nano chip assay. 
Samples that display a greater RNA index value were used for expression profiling. 500 ng 
RNA was used for cDNA synthesis. In the next step the Illumina® Total Prep™ RNA 
Amplification Kit (Life Technologies) was used to amplify/lable the samples in order to 
synthesize biotin-labeled cRNA, achieved by the addition of biotin-16-UTP (Roche Applied 
Science). The quality of purified cRNA was determined using the RNA Nano Chip Assay on 
an Agilent 2100 Bioanalyzer. The first hybridization step was performed at 58 °C with 100 ng 
cRNA/µL in GEX-HCB Buffer (Illumina) in a wet chamber for 20 h. Spike-in controls for low, 
medium, and highly abundant RNAs, mismatch control and biotinylation control 
oligonucleotides were added. The microarray chip was washed with High Temp Wash Buffer 
(Illumina) at 55 °C followed by two washing steps with E1BC Buffer (Illumina) at RT. In 
between the washing steps with E1BC Buffer, the microarray chip was washed with ethanol 
at RT. Next the chip was blocked using 4 mL blocking solution (1% (wt/vol) Blocker Casein in 
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phosphate buffered saline Hammarsten grade (Pierce Biotechnology) for 5 min, and the 
signals were developed by a 10 min incubation step in 2 mL Cy3-streptavidin (1 µg/mL; 
Amersham Bioscience) and 1% blocking solution. Finally the chip was washed with E1BC 
Buffer, dried and scanned.  
The microarray was scanned using the iScan Array Scanner (Illumina). The data were 
extracted for each bead individually and outliners (>2.5 median absolute deviation) were 
removed. The remaining values were used to calculate the mean average signal for a give 
probe, and a standard deviation for each probe was calculated.  
For data analysis the received raw data were uploaded to CHIPSTER software. All values 
(9 in total) were normalized to each other using CHIPSTER. To compare the values of the 
samples, a three group test (empiricalBayes) was done. Furthermore, the p.value adjustment 
method BH (Bejamini-Hochberg) was performed and the p.value threshold was set to 0.05. 
These calculations resulted in a list of 5471 genes. These genes were represented in a heat 
map, and hierarchically clustered by the added dendrogram (pearson distance method), 
which was clustered by samples and genes.  
The logarithmic fold changes of gene expression of NHK compared to hiPSCs and 10 day 
differentiated cells compared to hiPSCs were calculated using CHIPSTER.  
 
 
2.2.8 Protein biochemistry 
 
2.2.8.1 Protein Isolation 
 
To isolate proteins from adherent cells, cells were washed twice with PBS and 
Trypsin/EDTA was added. After 5 min at 37 °C cells were rinsed with washing medium 
(DMEM GlutaMAXTM containing 10% FBS) and transferred into a conical 15 mL tube. The 
cells were centrifuged at 1200 rpm for 5 min and the cell pellet was washed with PBS. After 
additional centrifugation PBS was aspirated and the cells were lysed with 50 µL lysis buffer 
(complete Mini tablet in 1xTBS supplemented with 0.1% Triton-x-100) (50 µL for < 5*106cells; 
100 µL lysis buffer for > 5*106 cells). The lysate was incubated for 15 min on ice, followed by 
centrifugation at 13.000 rpm and 4 °C for 15 min. From the protein containing supernatant 
10 µL were used to measure the concentration. The remaining protein was frozen at -80 °C. 
 
 
2.2.8.2 BCA Protein Assay 
 
To measure the concentration of a protein lysate the BCA (bicinchoninic acid) Protein 
Assay Kit (Thermo Scientific Pierce) was used. A standard curve for bovine serum albumin 
(BSA) was developed using the purified BSA standard, diluted to obtain following 
concentrations: 
  
 Conc. 1: 2.000 µg/µL   Conc. 6: 250 µg/µL 
 Conc. 2: 1.500 µg/µL   Conc. 7: 125 µg/µL 
 Conc. 3: 1.000 µg/µL   Conc. 8: 25 µg/µL 
 Conc. 4: 750 µg/µL   Conc. 9: H2O = Blank 
 Conc. 5: 500 µg/µL 
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Protein samples from the lysed cells were diluted 1:10 and 1:20 with H2O. 10 µL per 
sample were added to a well of a 96well plate. Each sample as well as the BSA standard 
concentrations were measured in duplicates. 
To every sample, 196 µL of BCA Reagent A and 4 µL of BCA Reagent B were added 
(BSA standard and protein samples). The plate was sealed and the solutions were mixed by 
shaking the plate for 90 sec using an orbital shaker. The plate was then incubated for 30 min 
at 37 °C. The absorbance was measured using a plate-reader at a wavelength of 560 nm. 
The replicated absorbance values of the BCA standard were averaged and the value of 
the blank was subtracted. Then the mean absorbance values were plotted against the 
standard protein concentration to generate a standard curve. In parallel the values of the 
protein samples were averaged, subtracted from the blank and multiplied by the dilution. The 
slope of the standard curve was used to calculate the concentration of each sample of 
interest according to its mean absorbance value. 
 
 
2.2.8.3 SDS page and Western Blot 
 
2.2.8.3.1 Preparation of SDS-polyacrylamide gels 
 
To separate proteins of a sample according to their size, SDS polyacrylamide gel 
electrophoresis (SDS-page) was performed. For preparing 10% polyacrylamide gels a 
spacer plate and a short plate were fixed in a casting frame and arranged in a casting stand. 
First the components of the separating gel were mixed as follows: 
   
  H2O   2 mL 
  30% Acrylamide 1.65 mL 
  1.5M Tris, pH 8.8 1.25 mL 
  10% SDS   50 µL 
  10% APS  50 µL 
  TEMED  2 µL 
 
The separating gel solution was applied in between the short glass plate and the spacer 
plate and rinsed with isopropanol until hardening, then the isopropanol was removed using a 
piece of filter paper. Then the components of the stacking gel were mixed as follows: 
   
H2O   1.4 mL 
  30% Acrylamid 330 µL 
  0.5M Tris, pH 6.8 250 µL 
  10% SDS   20 µL 
  10% APS  20 µL 
  TEMED  2 µL 
 
The stacking gel solution was carefully pipetted on the separating gel and the combs were 
immediately inserted into the gel. After hardening the gels were used for electrophoresis. 
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2.2.8.3.2 Sample preparation 
 
For each sample 25 µg protein were used, 2x Laemmli buffer was added at the 
appropriate amount and the sample was adjusted to a volume of 20-30 µL with lysis buffer. 
The probes were spun down and heated at 95 °C for 5 min. The Laemmli buffer contains ß-
mercaptoethanol, which reduces the intra and intermolecular disulfide bonds and SDS to 
denature the proteins. The probes were then loaded on the gel. 
 
 
2.2.8.3.3 Gel electrophoresis 
 
The polyacrylamide gels were fixed in the electrode assembly module and placed in a 
tank. Running buffer (25 mM Tris base, 0.19 M glycine, 0.1% SDS in H2O) was filled into the 
inner chamber, the space in between the two gels, and in the outside chamber. The combs 
were carefully removed from the gels. The probes and the protein ladder were then loaded 
into the wells. The electrophoresis device was plugged on a power supply and 
electrophoresis was run until the sample dye reaches the bottom of the gel, at 80V.  
 
 
2.2.8.3.4 Blotting 
 
After electrophoresis, the gel containing glass plates were taken out of the tank. The short 
glass was carefully lifted and the stacking gel was removed using a spatula. Then the gel 
holder cassettes were assembled in following order: cathode side, foam pad, 3 pieces of filter 
paper, gel, PVDF membrane, 3 pieces of filter paper, foam pad, anode side. The PVDF 
membrane was incubated for 2 min in methanol in order to activate its protein binding 
capacity, and then washed with water. The gel holder cassette was placed in the electrode. A 
cooling unit was fixed in the tank, transfer buffer was poured in and the whole tank was 
placed in a Styrofoam box filled with ice. Blotting was set up for 2h at 60V in order to transfer 
the proteins from the gel onto the PVDF membrane.  
 
 
2.2.8.3.5 Antibody staining and developing 
 
After the successful transfer of proteins from the gel onto the PVDF membrane, the 
membrane was removed from the gel holder cassette. In order to block non-specific antibody 
binding, the membrane was incubated in blocking buffer (1xTBS with 0.02 Tween 20 and 5% 
milk powder) (for western blot) for 1h at RT on an orbital shaker. The membrane was then 
placed into a conical 50 mL tube. Primary antibody was diluted in 10 mL in blocking buffer, 
and added to the membrane (used antibodies and concentrations are described in section 
“2.1.6 Primary Antibodies”). The membrane was incubation in antibody solution over night at 
4 °C on a roller mixer. The next day the membrane was washed three times for 10 min with 
washing buffer (1xTBS, 0.02% Tween 20) on an orbital shaker. Then the secondary antibody 
was diluted in 10 mL blocking buffer and incubated for 1 h at RT while shaking. The 
membrane was washed three times for 10 min with washing buffer on an orbital mixer.  
To detect the antibody binding Amersham™ ECL™ Prime Western Blotting Detection 
Reagent (GE™ Healthcare) was used. It is a chemiluminescent substrate to detect the 
horseradish peroxidase activity of the secondary antibody. For this treatment Solution A and 
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Solution B were mixed at the ration of 1:1, poured on the membrane and incubated for 1 min 
while shaking. The membrane was then transferred into an autoradiography cassette. The 
evaluation of the signal intensity was performed by exposing a photographic film (Amersham 
Hyperfilm™ ECL).  
To control if every lane owns the same amount of loaded protein loading controls were set 
up. Therefore an additional antibody staining was performed on the same membrane by 
using a primary antibody against the housekeeping gene ß-actin. The staining and 
development of the film was performed as described above.  
 
 
2.2.8.4 Immunofluorescence staining of cells  
 
For immunofluorescence stainings, cells grown on coverslips were washed twice with 
PBS in order to remove dead and floating cells. Cells were fixed with 4% paraformaldehyde 
in PBS for 30 min. After incubation cells were rinsed three times with PBST (0.1% Triton-x-
100 in 1x PBS).  
Cells were then treated with blocking buffer (3% BSA, 0.1% Triton-x-100 in 1x PBS) (for 
immunofluorescence stainings, IF) for 45 min to prevent unspecific antibody binding. Primary 
antibodies were diluted in blocking buffer (for antibody dilutions see “Material” part). 500 µL 
antibody-solution was added per coverslip and incubated over night at 4 °C. The primary 
antibody solution was aspirated and cells were washed three times for 5 min with PBST. The 
secondary antibody was diluted in blocking buffer 1:1 with PBS, 500 µL per coverslip were 
added and incubated for 1 h at room temperature, under exclusion of light. After aspirating 
the secondary antibody solution, cells were rinsed three times with PBS. Stainings of the 
nuclei were performed with 4´,6-diamidino-2-phenylindole (DAPI) fluorescent stain. In PBS 
diluted DAPI (1 µg/mL) was added to the cells and incubated for 5 min, followed by three 
washing steps with PBS. For permanent preservation of stained cells, object slides were 
labeled and coverslips were fixed with mounting medium on the object slides. Imaging was 
performed using an inverted microscope (Nikon). 
 
 
2.2.8.5 Flow cytometry analysis 
 
Flow cytometry is a method used for sorting and counting cells by size, granularity or the 
expression of certain markers after fluorescence staining. It is a laser-based method, where 
single cells in suspension are passing the lasers in a fluid stream, allowing them to analyze 
their characteristics, including size, granularity or fluorescent tag.  
To prepare the cells for the staining, the FIX&PERM® cell permeabilization kit (ADG) was 
used and performed according to manufacturer´s protocol, with minor changes.  
Grown cells were washed twice with PBS and Trypsin/EDTA was added to the cells. After 
5 min at 37 °C, washing medium (DMEM GlutaMAXTM containing 10% FBS) was added, the 
cells were rinsed and transferred into a conical tube. After centrifugation for 5 min at 
1200 rpm the supernatant was aspirated, the pellet was resuspended in PBS, the cell 
number was determined using a hemocytometer. The samples were then divided in order to 
prepare three conditions for each sample: non stained cells, cells stained only with the 
secondary antibody and cells stained with primary and secondary antibody. After an 
additional centrifugation step the pellets were resuspended in 100 µL Reagent A  
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(fixation reagent, provided with the kit) and incubated for 15 min at RT. Then, 5 mL PBS 
were added to each sample in order to dilute the fixation reagent, and the cells were spun 
down for 5 min at 1200 rpm. In the meantime the primary antibody K18 was diluted 1:50 in 
Reagent B (permeabilization reagent, provided in the kit). The supernatant was aspirated, 
the cells were resuspended in 100 µL Reagent B/primary antibody dilution and incubated for 
30 min at RT. After incubation, 5 mL PBS were added and the samples were spun down, 
washed with PBS and again spun down. The secondary antibody was diluted in Reagent B 
(1:500), and 100 µL of this dilution was added to the cells, followed by 30 min incubation at 
RT. The cells were then washed twice with PBS and passed through a 70 µm cell strainer. 
This step is important in order to avoid cell clumps, which block the cell stream during flow 
cytometry. The cells were then again centrifuged and resuspended in 500 µL FACS buffer 
(PBS supplemented with 2% BSA and 0.2% sodium azide) and transferred into a 5 mL FACS 
tube. The samples were measured with the BD FACSCanto™II cell analyzer using the BD 
FACSDiva™ Software and analyzed with FlowJo Analytical Software.  
 
 
2.2.9 Teratoma assay 
 
2.2.9.1 Sample preparation and injection 
 
The teratoma assay is a very stringent test to verify the pluripotency of stem cells and 
reprogrammed cells.  
HiPSCs were cultured on thin MatrigelTM coated (see section “2.2.2.2.1 Thin Matrigel™ 
coating”) 10 cm cell culture dishes in mTeSRTM1 medium (supplemented with 50 µg/mL 
Normocin™). The cells were rinsed twice with DMEM/F12, CTK solution was added to the 
cells and incubated for 7 min at 37 °C. The CTK solution was aspirated and the cells were 
washed twice with PBS. Then 840 µL ice-cold PBS were added to the colonies, which were 
then scraped in order to detach them from the cell culture plate, while preserving the colony 
formation. One 50-80% confluent 10 cm cell culture dish yielded six injections of 140 µL. The 
cell clump suspension was divided into six aliquots of 140 µL, and 60 µL undiluted MatrigelTM 
(30%) were added to the aliquots. The aliquots were kept on ice until injection to prevent 
Matrigel solidification.  
Two NOD-SCID mice were held and 200 µL were injected subcutaneously into each flank. 
After 12 weeks the mice developed teratomas. They were sacrificed, dissected and the 
teratomas were carefully removed. Teratomas were fixed in 4% formaldehyde overnight, and 
paraffin embedded as described in the following paragraph. 
 
 
2.2.9.2 Paraffin embedding and hematoxylin and eosin staining of teratomas 
 
The isolated teratomas were fixed in 4% formaldehyde at RT overnight. Embedding in 
paraffin requires processing of the tissue. Therefore the teratomas were placed in a Tissue 
Processor (Leica), were the dehydration, clearing, and infiltration with paraffin takes place. 
Dehydration is ensured by incubating the tissue in baths of progressively increasing alcohol 
concentrations followed by the paraffin infiltration steps in the following order: 
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  10% formalin    1.5 h 
  10% formalin    1.5 h 
  70% ethanol     1.5h 
  80% ethanol     1.5 h 
  96% ethanol     1.5 h 
  99% ethanol    1.5 h 
  99% ethanol    1.5 h 
  xylene     1.5 h 
  xylene     1.5 h 
  paraffin 55 °-65 °C   1.5 h 
  paraffin 55 °-65 °C   1.5 h 
  paraffin 55 °-65 °C   1.5 h 
 
After removing the samples from the Tissue Processor, they were placed in a metal box, 
which serves as a frame for the embedding. The tissue was then doused with paraffin and 
left to cool down for 30 min. After paraffin hardening, the metal frame was removed and 1 µm 
thick sections were prepared using a microtome.  
 
The hematoxylin and eosin (HE) staining is a routinely and most widely used staining in 
hematology. It serves to distinguish different structures of tissues. The staining based on the 
addition of hematoxylin, which stains basophilic structures, including the nuclei. After 
applying hematoxylin the nuclei show a brownish-red color. The addition of water increases 
the pH and leads to a color change into blue. The second dye is eosin, which stains 
eosinophilic structures, like the cytoplasm, in various shades of red. The staining steps were 
performed in following order: 
 
  xylene    10 min 
  99% ethanol   5 min 
  95% ethanol   5 min 
  70% ethanol   5 min 
hematoxylin   3 min 
dH2O    5 min 
4% acetic acid   90 sec 
eosin    90 sec 
dH2O    5-10 sec 
70% ethanol   5 min 
96% ethanol   5 min 
99% ethanol   5 min 
xylene    5 min 
 
In the last step the sections were mounted with Eukitt® mounting medium.  
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3 Results 
 
3.1 Pluripotency verification of reprogrammed cells  
 
Induced pluripotent stem cells offer a great promise for therapeutic purposes, especially 
because of their ability to differentiate into all cells of the mammalian body. In order to use 
reprogrammed cells, they have to be examined for their pluripotency, their ability to 
differentiate into all cells of the mammalian body and their ability to self-renew indefinitely. 
Therefore, a number of required tests have to be performed to prove their pluripotent state 
and to demonstrate their similarity to human embryonic stem cells (hESCs). In a first step the 
morphology of the generated hiPSC line D1 was examined. HESCs grow in colonies of small 
cobblestone-like cells and are tightly packed with sharp edges. During the reprogramming 
process and also after establishing stable hiPSCs lines, the cells were investigated for their 
morphology. Figure 3 shows the generated hiPSC line D1. The cells had the desired 
morphology of sharp-edged colonies with small cobblestone like cells.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Pluripotent cells also display elevated levels of alkaline phosphatase on their cell 
membrane (Martí et al., 2013), which serves as a marker for pluripotency. Figure 4 shows 
the positive alkaline phosphatase staining of the hiPSC line D1. 
During the reprogramming process, the RNA expression levels of certain genes alter. 
Stem cells display the expression of certain pluripotency-associated markers. Figure 5 shows 
the expression levels of pluripotency-associated markers LIN28, SOX2, REX1, TERT and 
NANOG of the generated hiPSC line D1 compared to NHKs, analyzed by QPCR. 
Furthermore, the cells were tested for the expression of pluripotency-associated genes on 
protein level. Immunofluorescence stainings performed on fixed hiPSC line D1 showed the 
expression of OCT4, NANOG, SSEA4, TRA-1-60 and TRA-1-81 (Figure 6). OCT4 and 
NANOG were localized in the nucleus, whereas SSEA4, TRA-1-60 and TRA-1-81 are 
surface markers. Immunofluorescent stainings of the hiPSC line D1 showed clear expression 
of all tested markers, as a proof for their pluripotency.  
Figure 4: Alkaline phosphatase staining of hiPSC line D1. Scale bar: 100µm 
Figure 3: Bright field images of hiPSC line D1. Scale bar: 100 µm 
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Figure 5: Expression quantities of 
pluripotency associated markers in 
hiPSCs compared to NHKs. QPCR 
expression analysis of SOX2, LIN28, 
REX1, TERT and NANOG in human 
induced pluripotent stem cells 
(hiPSCs). Normalized to GAPDH. 
Normal human keratinocytes were 
used as a reference sample. 
Figure 6: Immunofluorescence 
stainings of pluripotency 
associated markers on human 
induced pluripotent stem cell 
colonies. The images show 
nuclear NANOG and OCT4 
stainings and the corresponding 
staining of the nucleus. The staining 
images for the surface markers 
TRA-1-60, TRA-1-81 and SSEA4 
are merged with the nuclei staining. 
Nuclei were stained with 4′,6-
Diamidin-2-phenylindol (DAPI). 
Scale bars are 50 µm. 
NANOG DAPI 
OCT4 DAPI 
SSEA4  DAPI SSEA4  DAPI 
TRA-1-60  DAPI TRA-1-81  DAPI 
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The most stringent of the pluripotent state of a cell is the teratoma assay. HiPSCs D1 
were injected, as previously described (“2.2.9 Teratoma assay”), subcutaneously into the 
flanks of two NOD-SCID mice. Both mice developed teratomas after three months (Figure 
7A). The teratomas were fixed, paraffin embedded and the prepared sections were stained 
for H&E. The teratomas contained pigmented cells and epidermal structures, representing 
the ectodermal lineage (Figure 7B, first row). Furthermore, muscle fibers and cartilage, 
originating from the mesoderm and gut-like epithelium with endodermal origin, were 
detected.  
The performed experiments proved the pluripotent state of the generated hiPSCs on RNA 
and protein level and in an in vivo experiment.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7: Teratoma assay indicating the pluripotent state of injected human induced pluripotent stem cells 
(hiPSCs). (A) HiPSCs were injected subcutaneously into an immunodeficient mouse. The mouse was sacrificed after 
teratomas developed. The teratomas were excised and the size was measured. (B) Hematoxylin and eosin staining 
of teratomas. The excised teratomas were fixed and paraffin embedded. Sections were prepared and Hematoxylin 
and eosin stained. Shown are selected parts of ectodermal, mesodermal, and endodermal tissue. Magnifications 
were 40x for the upper panel, 60x for the lower panel. 
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3.2 Differentiation of human induced pluripotent stem cells into keratinocytes 
 
In the field of dermatology, the differentiation of hiPSCs into keratinocytes is of particular 
interest, in order to generate skin equivalents. Therefore, hiPSCs were differentiated into 
keratinocytes, according to the differentiation protocol of Itoh and colleagues (Itoh et al., 
2011) with minor changes (changes are described in section “2.2.4 Epithelial differentiation 
protocol”). Figure 8 shows the differentiation procedure. Cells were differentiated for 30 days, 
and harvested every 5 days for RNA isolation or fixed for further stainings. In addition, cells 
were imaged every 5 days, to record the differentiation progress (Figure 9).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8: Schematic illustration of differentiation experiment. HiPSCs were seeded at single cells and 
differentiated for 30 days. Cells were harvested every 5 days. 
Figure 9: Bright field images of differentiated cells derived from human induced pluripotent stem cells.
Shown are cells imaged at different time points, and normal human keratinocytes (NHK) for comparison. 
Magnification 10x.  
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Bright field images of the differentiating cells showed changes in morphology. Already at 
day 5 the morphology resembled that of epithelial cells rather than hiPSCs. To prove that the 
cells also undergo molecular changes, the expression of pluripotency-associated as well as 
keratinocyte markers was determined by QPCR. Figure 10A shows the QPCR results of one 
differentiation experiment, representative of three performed experiments. The data showed 
a clear decrease in expression of pluripotency-associated markers SOX2 and LIN28. While 
the expression of SOX2 on day 0 (represents undifferentiated hiPSCs) was 18,000 fold 
higher compared to NHK, it decreased strongly to a 3600 fold change on day 5, 236 fold 
change on day 10, and to a not detectable expression on day 30. The expression of the 
pluripotency-associated marker LIN28 displayed a similar tendency, showed a strongly 
decreasing expression, but remained ~25fold increased compared to NHK.  
While the expression of pluripotency-associated markers diminished during the 
differentiation, the cells started to express epidermal markers (Figure 10B). Keratin 8 (K8) 
and keratin 18 (K18) are usually expressed by simple, single layered epithelia and during the 
embryonic development of the epidermis before stratification begins. During the in vitro 
differentiation of hiPSCs, the cells began to express K8 and K18, and the levels of both 
genes rose until day 15. From day 15, expression of K8 and K18 was replaced by the 
expression of another pair of keratins, keratin 5 (K5) and keratin 14 (K14). During embryonic 
development, the epidermis displays a single-layered epithelium, with cells expressing K8 
and K18. As soon as the stratification begins, these keratins are replaced by K5 and K14, 
which are expressed in the basal layer of the stratified epithelium. Furthermore, differentiated 
hiPSCs at d5 started to express p63, which is an important regulator of keratinocyte 
differentiation, and responsible for the switch from K8 and K18 to K5 and K14 (Koster et al., 
2004a). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10: QPCR analysis of cells at several differentiation steps. (A) Relative expression quantities of 
SOX2 and LIN28 during differentiation. (B) Expression levels of keratin 8, keratin 18, keratin 5, keratin 14, 
integrin-α-6 and p63. Normalization with GAPDH, all values are relative to normal human keratinocytes (NHKs). 
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To demonstrate the expression of keratinocyte markers on protein level, 
immunofluorescence stainings of differentiated cells at several time points were performed 
(Figure 11). As already proved by QPCR, the cells showed a clear nuclear staining for p63 
beginning on day 5, and K14 staining on day 20. In addition, markers for suprabasal layers, 
including involucrin (Inv) and keratin 1 (K1), could be detected on day 25.  
To further prove that the differentiation protocol drives the cells towards a keratinocyte 
fate, a genome wide gene expression analysis (Microarray) was performed, to compare 
hiPSCs, cells differentiated for 10 days and NHK. All statistically significant genes (p.value ≤ 
0.05) are displayed in a heatmap, hierarchically clustered in a dendrogram, as shown in 
figure 12. The analysis demonstrated that, as expected, the biological replicates grouped 
together. Furthermore, differentiated cells still clustered closer to hiPSCs than to NHK. This 
result was not surprising, since cells differentiated for 10 days still represent a progenitor 
stage.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11: Immunofluorescence images of hiPSC-derived keratinocytes at several differentiation steps.
Antibodies against keratinocyte markers p63, keratin 18 (K18), keratin 14 (K14), involucrin (Inv) and keratin 1 (K1) 
were used. Nuclei were stained with DAPI. Scale bars: 100 µm. 
Figure 12: Dendrogram based on gene 
expression array results. Gene expression 
analysis of normal human keratinocytes (NHK), 
human induced pluripotent stem cells (hiPSCs) and 
cells differentiated for 10 days (d10), in biological 
triplicates. Heatmap of statistically significant genes, 
hierarchically clustered in a dendrogram. 
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In order to investigate the genes that are correlated to pluripotency and keratinocyte 
development, genes of interest were selected from the list of all statistically significantly 
regulated genes, and the fold changes were calculated (Figure 13). Pluripotency-associated 
genes, including SOX2, ZIC3 LIN28a or LIN28b, were significantly downregulated in 
differentiated cells compared to hiPSCs, and in NHK compared to hiPSCs. In addition, 
keratinocyte markers, including integrin-ß1 (ITGB1), TP63 or collagenVII were upregulated in 
differentiated cells and NHK compared to hiPSCs.  
Taken together, a differentiation protocol was established and hiPSCs could be 
differentiated into early keratinocytes. Regarding the gene expression, the generated cells 
showed an upregulation of epithelial/keratinocyte markers, whereas the pluripotency-
associated markers diminished.    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13: Significant fold 
changes of pluripotency 
associated genes and 
keratinocyte markers.
Compared are fold changes in 
cells differentiated for 10 days 
(d10) and human induced 
pluripotent stem cells (hiPSCs)
(red) and normal human 
keratinocytes (NHK) were 
compared to hiPSCs (blue). 
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3.3 High-throughput siRNA screen of differentiating human induced pluripotent 
stem cells  
 
The expression of a specific protein can be knocked-down by transfecting cells with 
siRNAs. The siRNAs bind specifically to the mRNA with the complementary sequence (RNA 
interference) and thereby induce its degradation. The knock-down of genes is a common 
method to analyze their function. This method can help to find relevant factors or new 
pathways that are important for differentiation process. Furthermore, siRNA knock-down can 
be scaled up to high-throughput which enables the analysis of a lot of genes in one 
experiment.  
The aim was to adapt the differentiation of hiPSCs into early epithelial cells to a high-
throughput siRNA screen. 
For the high-throughput siRNA screen, cells were seeded as single cells on 384well plates 
and transfected with the kinome siRNA library of ~800 siRNAs (siGenome, Dharmacon) 
(Figure 14). The cells were differentiated for 10 days under these conditions.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
For the read-out the cells were stained against K18. K18 is usually expressed in simple, 
single layered epithelia and during embryonic development of the epidermis, before the 
epidermis begins to stratify. In vitro differentiation experiments presented before revealed 
that K18 was expressed at day 10, and it therefore represents a suitable marker to follow 
epithelial progenitor development. After imaging the stained cells, the number of K18 positive 
cells was determined, the values were normalized per assay plate and the z-scores were 
calculated (cellHTS2 software). The z-score represents the relationship of a certain sample 
to the mean of a group and thus generates a hit list of all used conditions .Figure 15A 
displays the distribution of the positive and the negative controls in the screens. The positive 
control yielded a mean value of 8.6% K18 positive cells and the negative control 0.5%. 
Furthermore, figure 15B shows the distribution of the controls by their z-scores, which 
indicates a clear distinction between positive and negative control.  
 
 
 
 
 
 
 
 
Figure 14: Schematic diagram of screen work flow. HiPSCs were seeded at single cells on siRNA containing 
384well plates. Fresh medium was added on day 5. The cells were differentiated for 10 days followed by 
immunofluorescence staining against keratin 18 (K18). Cells were imaged by automated microscopy. 
Figure 15: High-throughput 
siRNA screen analysis. (A) 
The boxplot depicts the ratio of 
the keratin 18 positive cells 
(K18⁺) and the total cell number 
in the positive and the negative 
control. (B) Distribution of the 
positive and negative controls.    
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Up next, the z-score distribution of all siRNAs was investigated. As shown in figure 16, the 
negative (red) and positive (blue) samples grouped together, the positive controls at a value 
of -1 and the negative controls at a value of 1.3. Samples with a z-score lower than the 
positive control displayed higher amounts of K18 cells, and were of major interest. The top 
50 candidates, with the lowest z-scores were investigated for their morphological differences 
compared to the positive controls. Figure 17 shows the immunofluorescence staining of the 
candidates HIPK4 and ADCK2, and the positive control for comparison.  
Cells treated with siRNA against HIPK4 displayed a bigger cytoplasmic portion, more K18 
fibers and fewer colonies of unstained cells, compared to the positive control. In contrast, 
nearly no K18 signals were detected in cells transfected with siRNA against ADCK2. HIPK4 
was chosen for further analysis, due to the obtained screen results and because of the 
described morphological changes. It was of interest, to further analyze the role of HIPK4 
during the epithelial determination.  
In summary, the high-throughput screen is an effective method to screen numerous 
factors in a short time period. The high-throughput screen performed during the 
differentiation of hiPSCs into an epithelial lineage resulted in a list of potential candidates, for 
example HIPK4 and ADCK2, which are suggested to influence the differentiation process.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 16: Distribution of the z-score values of all siRNAs. Blot includes negative (red) and positive (blue) 
controls. Arrows mark HIPK4 as a sample with increased numbers of keratin 18 positive cells, indicated by a 
lower z-score, and ADCK2 with decreased numbers of keratin 18 positive cells, indicated by a higher z-score.  
Figure 17: High-throughput siRNA screen read-out. Not transfected cells (positive control), cells transfected 
with siRNA against HIPK4 and against ADCK2 were differentiated for 10 days. These cells were then stained for 
keratin 18 (K18, red) and DAPI (nuclei stain, blue). Magnification: 20x. 
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3.4 Investigating the role of HIPK4 during early epithelial differentiation 
 
3.4.1 The effect of HIPK4 knock-down on keratin 18 expression during early epithelial 
differentiation  
 
After choosing HIPK4 as a candidate of interest, detailed investigations were performed. 
First the expression of HIPK4 during 30 days of differentiation was analyzed. Figure 18 
shows the expression levels of HIPK4 during the differentiation process. Compared to NHK, 
hiPSCs (d0) showed an increased expression of HIPK4. The expression level decreased 
slightly until day5, but increased again until reaching a peak on day 15. After day 15 the 
expression levels declined again.  
 
 
 
 
 
 
 
 
 
In order to validate the knock-down efficacy of the siRNA against HIPK4 on protein level, 
the differentiation with HIPK4 siRNA transfected hiPSCs was repeated in larger scale and 
protein was isolated at different time points. Figure 19 depicts the performed experiment. 
HiPSCs were dissociated into single cells and seeded on Matrigel™ coated cell culture 
plates. The next day, the cells were transfected with a pool of four siRNAs against HIPK4 
and a pool of non-targeting siRNAs and differentiated for 10 days. The Cells were harvested 
on day 5 and day 10 and protein was isolated at both time points. Figure 20 shows a clear 
knock-down of HIPK4 compared to the control on day 5 of differentiation, detected by 
western blot. The transfection with siRNAs is transient, thus the knock-down effect lasts for a 
limited time. Because of that, a slight increase in protein expression was detected on day 10. 
ß-Actin served as a loading control.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 18: HIPK4 expression values during in 
vitro differentiation of hiPSCs into 
keratinocytes. Normalized to GAPDH and 18S. 
Reference sample NHK.  
Figure 19: Illustration of the experimental set-up. HiPSCs were seeded at single cells on Matrigel™ coated 
plates. The next day cells were transfected with siRNAs. On day 4 medium was switched to defined keratinocyte 
serum free medium (DKSFM) without BMP and retinoic acid (RA). Cells were harvested on day 5 and day 10. 
Figure 20: Western blot analysis of cells transfected with 
HIPK4 and non-targeting (control) siRNA. Cells were 
differentiated and harvested on day 5 and 10. Loading 
control: ß-Actin. Negative control: HaCat cells. 
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Figure 21 shows the QPCR analysis of differentiated cells which were either transfected 
with the pool of four HIPK4 siRNAs (blue bars), a pool of non-targeting siRNAs (siControl, 
yellow bars) or non-treated cells (gray bars). As already mentioned, the knock-down of 
HIPK4 was transient. Cells transfected with HIPK4 siRNAs expressed half as much HIPK4 
compared to cells transfected with the non-targeting control. This effect was not persistent 
until day 10, where the expression level of HIPK4 was similar under both treatment 
conditions. The analysis revealed further that the knock-down of HIPK4 during early 
epidermal differentiation led to a significant increase of K8 and K18 expression, compared to 
the control- or non-treated cells. In addition, also the expression levels of K5 and K14 were 
significantly increased when cells were treated with siRNA against HIPK4. The depicted 
graphs demonstrate one experiment representative for three biological replicates.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 21: Expression values of keratinocyte markers in differentiated hiPSCs upon HIPK4 knock-down.
Relative quantities of HIPK4, keratin 8, keratin 18, keratin 5, and keratin 14 RNA in cells differentiated for 5 and 
10 days and transfected with HIPK4 siRNA (siHIPK4 d5, siHIPK4 d10), non-targeting siControl (siControl d5, 
siControl d10), and not treated cells (no treatment d5, no treatment d10). Normalized to GAPDH and 18S. Normal 
human keratinocytes (NHK) served as reference sample. Shown are results of one experiment, representative for 
3 biological replicates. **: p.value < 0.01; ***: p.value <0.001.   
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Furthermore, differentiated cells were investigated for their expression of K18 antigens by 
flow cytometry. Figure 22 depicts flow cytometry analysis of untreated cells, cells transduced 
with a non-targeting siRNA (siControl) and transduced with siRNAs against HIPK4 (siHIPK4) 
after 10 days of differentiation. Unstained cells and secondary antibody stained cells were 
measured to set the gates.  
The analysis confirmed the previous findings by showing an increased number of K18 
positive cells (17.1%) compared to the siControl treated cells (11%) and the untransfected 
(untreated) cells (8.92%).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
To further investigate morphological differences of differentiated cells after HIPK4 knock-
down, immunofluorescence staining was performed. Figure 23 shows K18 stainings of cells 
which were differentiated for 10 days with and without HIPK4 knock-down. The cytoskeleton 
of cells which were transfected with HIPK4 siRNA was composed of larger and more 
interconnected fibers and a bigger cytoplasmic portion. This indicates a more advanced 
differentiation stage of cells which turn from a pluripotent into an early epithelial state. 
In order to prove that this effect was not restricted to one specific hiPSC line, the 
experiment was repeated with the hiPSC line VG2, which was derived from another donor. 
Figure 22: Flow cytometry analysis of differentiated hiPSCs upon HIPK4 knock-down. HiPSCs were 
transfected with siRNAs against HIPK4 (siHIPK4) or with non-targeting siRNAs (siControl) and differentiated for 
10 days. Cells were then stained with an antibody against keratin 18 (K18) and the number of K18 positive cells 
quantified by flow cytometry. Unstained cells and cells only stained with the secondary antibody (2nd AB control) 
served ass control conditions. Gates were set on siControl treated cells only stained with the 2nd AB.  
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As depicted in figure 24, the transfection with HIPK4 siRNAs led to the reduction in HIPK4 
expression in treated cells (blue bar) on day 5, compared to the cells transfected with non-
targeting siRNA (yellow bar) on day 5. The knock-down of HIPK4 in turn, resulted in 
increased expression of K18 on day 10.  
In summary, the knock-down of HIPK4 in hiPSCs increased the expression of keratins 
after 10 days of subsequent differentiation.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 23: Immunofluorescence staining of Keratin18 (K18) on differentiated hiPSCs upon HIPK4 knock-
down. HiPSCs were transfected with siRNAs against HIPK4 (siHIPK4 treated) or a non-targeting control 
(siControl treated) and subsequently differentiated into early epithelial cells. After 10 days of differentiation, cells 
were stained against keratin18 (K18, green). Nuclei were stained with 4′,6-Diamidin-2-phenylindol (DAPI). Scale 
bars: 100 µm.   
Figure 24: QPCR analysis of differentiated 
hiPSC line VG2 upon HIPK4 knock-down. Cells 
were transfected with siRNA against HIPK4 
(siHIPK4) and a non-targeting siRNA (siControl) 
and differentiated for 10 days. Quantitative 
expression of HIPK4 and keratin 18 was analyzed 
after 5 (d5) and 10 days (d10) of differentiation. 
Normalized to GAPDH and 18S. Reference 
sample: VG2 siControl d10.   
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3.4.2 Transfection of hiPSCs with single siRNAs against HIPK4 
 
In order to achieve a strong knock-down of a certain gene by using siRNAs, it is common 
to use a pool of siRNAs against different sequence locations. The drawback of this method is 
that some siRNAs can cause an off-target effect on the expression of other genes, instead of 
knocking-down the gene of interest. To prove that the used pool of four HIPK4 siRNAs 
results in the knock-down of HIPK4 and thus in an increase of K18 expression levels, the 
differentiation experiment was repeated by using the four single siRNAs against HIPK4 
separately (Figure 25).  
 
 
 
 
 
 
 
 
 
HiPSCs were seeded on MatrigelTM coated dishes and the next day they were transfected 
with single siRNAs (siNo.9, siNo.10, siNo.11, and siNo.12). After 5 and 10 days of 
differentiation, the cells were harvested and total RNA was isolated. The expression of 
HIPK4 and K18 was analyzed by QPCR. The analysis shown in figure 26 revealed that every 
single siRNA against HIPK4 leads to a knock-down of the gene although not to a similar 
level. The transfection with siNo.9 and siNo.12 resulted in the strongest knock-down, with 
20% and 34% reduced expression on day 5, whereas siRNA No.11 and siNo.12 transfection 
yielded 2.5% and 10% knock-down efficiency on day 5 compared to the siControl treated 
cells.  
As already mentioned, the transfection with siRNA is transient, thus the knock-down effect 
was detectable on day 5 before the expression levels increased again until day 10. The 
knock-down of HIPK4 resulted in increased expression levels of K18 after 5 and 10 days of 
differentiation. The levels of K18 expression increased at day 10 by 29% for siNo.9, 23% for 
siNo.10, 30% for siNo.11, and even 37% for siNo.12, compared to the control treatment.  
Taken together, the transfection of hiPSCs with single siRNAs against HIPK4 and the 
subsequent differentiation into early epithelial cells led to the knock-down of HIPK4 and 
resulted in the upregulation of K18 after 5 and 10 days. This indicates that the upregulation 
of keratins and epithelial markers including p63, is not an off-target effect of the used 
siRNAs.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 25: Pool of four single siRNAs against 
HIPK4. HIPK4 siRNA pool, composed of 4 single 
siRNAs (siRNA No.9, siRNA No.10, siRNA No.11, and 
siRNA No.12).    
Figure 26: Expression analysis of differentiated hiPSCs transfection with single siRNAs against HIPK4. 
HiPSCs were transfected with four different siRNAs against HIPK4 (siNo.9, siNo.10, siNo.11 and siNo.12; blue 
bars) and non-targeting siRNA (siControl, yellow bar) and differentiated for 10 days. The expression level of HIPK4 
and keratin 18 was determined by QPCR after 5 (left graphs) and 10 days (right graphs) of differentiation. Analysis 
was normalized to GAPDH. SiControl d10 served as reference sample. 
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3.4.3 Serial knock-down of HIPK4 during early epithelial differentiation of hiPSCs 
 
As shown before, the transfection of hiPSCs with a pool of siRNAs against HIPK4 was 
transient. While the knock-down of HIPK4 was detectable on RNA and protein level on day 5 
of differentiation, the effect was diminished on day 10. Nevertheless, the knock-down of 
HIPK4 led to the increase of keratin expression levels after 10 days of differentiation, which 
suggests the involvement of HIPK4 in very early events of differentiation. It was of interest to 
determine if a persistent knock-down during the differentiation of hiPSCs into early epithelial 
cells would result in even accelerated keratin expression levels. Therefore hiPSCs were 
again seeded for differentiation and transfected twice, on day 1 and on day 5 (2x) with a pool 
of siRNAs against HIPK4 and a non-targeting siControl, as shown in figure 27. In order to 
compare the results with the aforementioned experiments, one batch was only transfected 
once on day 1. The cells were differentiated under mentioned conditions for 10 days. Total 
RNA was isolated and the expression levels of epithelial markers on day 10 were analyzed.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
As shown in figure 28, a single knock-down of HIPK4 was not detectable anymore on day 
10. In contrast, cells which were transfected twice (HIPK4 2x), still exhibited a persistent 
knock-down. Interestingly, the persistent knock-down of HIPK4 could not further increase the 
expression levels of keratins as well as the level of p63. The single knock-down of HIPK4 at 
the beginning of the differentiation process yielded the highest expression levels for all tested 
epithelial markers, as demonstrated in previous experiments. In contrast, cells with a 
persistent knock-down of HIPK4 did not show increased levels of keratins or of p63, but 
rather had expression levels comparable to the control cells.  
From these results, one could suggest that HIPK4 might have an inhibitory role during the 
very early steps of development, but may be required for proper development after this initial 
phase. 
 
 
 
Figure 27: Schematic of serial transfection work flow. HiPSCs were seeded on Matrigel™ coated dishes for 
10 days of differentiation into early epithelial cells. Defined keratinocyte serum free medium (DKSFM) was used 
for the directed differentiation, and supplemented the first 4 days with retinoic acid (RA) and bone morphogenetic 
factor 4 (BMP4). Cells were transfected either on day 1 and harvested on day 10 (1X), or transfected on day 1 
and day 5 and harvested on day 10 (2X). 
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3.4.4 The effect of HIPK4 knock-down under different culture conditions  
 
The knock-down of HIPK4 during the very early differentiation steps led to an increase of 
epithelial markers, but a persistent knock-down did not increase their expression. 
Nevertheless, it is still unclear how HIPK4 affects the expression of epithelial markers.  
For this reason, it was investigated whether the supplements in the differentiation medium 
have an influence on the upregulation of keratins induced by the HIPK4 knock-down. HiPSCs 
were seeded for differentiation under four different culture conditions for the first four days of 
differentiation. As depicted in figure 29, the cells were cultivated either in defined 
keratinocyte serum free medium (DKSFM) supplemented with retinoic acid (RA) and BMP4 
(usual condition), DKSFM with RA, DKSFM with BMP4, or DKSFM without supplements. On 
day 4 the medium was replaced by DKSFM without supplements. RNA was isolated on day 5 
and day 10. Furthermore bright field images were made to monitor morphological changes.  
 
 
Figure 28: QPCR analysis of differentiated cells after serial knock-down. HiPSCs differentiated for 10 days 
were transfected on day 1 (1x) or on day 1 and 5 (2x) with siRNAs against HIPK4 (siHIPK4) or with a non-
targeting control siRNA (siControl). The expression levels of HIPK4, p63, keratin 8, keratin 18, keratin 5 and 
keratin 14 were analyzed. Analyses were normalized to GAPDH and 18S. Normal human keratinocytes (NHK) 
served as reference sample.  
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Figure 30 shows bright field images of cells after 10 days of differentiation under 
described culture conditions, with and without HIPK4 knock-down. Furthermore, it depicts 
QPCR analysis from the different conditions after 5 and 10 days. The first culture condition, 
DKSFM supplemented with RA and BMP4 was routinely used for differentiation. As shown in 
previous experiments, the knock-down of HIPK4 was detectable on day 5, but not on day 10. 
Compared to the non-targeting siControl, the transfection with siRNA against HIPK4 yielded 
a knock-down of 90%. As already shown in previous experiments, a detectable knock-down 
of HIPK4 on day 5 resulted in an upregulation of K18 on day 10 (one and a half higher more) 
compared to the non-targeting control. As seen on the bright field images, both treatments 
(siHIPK4 and siControl) resulted in a heterologous population of differentiating cells. Large 
colonies of epithelial-like cells could be found in between other cell types, but no stem cells 
like colonies were present.  
The second condition, DKSFM with RA, showed similar results. QPCR analysis revealed 
a 46% knock-down of HIPK4 on day 5 after treatment with siRNAs against HIPK4, 
accompanied with an increase of K18 at day 10. Interestingly, the non-targeting siRNA 
treated cells showed no increase in K18 on day 10 compared to day 5. Bright field images 
illustrate the presence of epithelial-like colonies, surrounded by a heterologous cell 
population in both conditions. Furthermore, no stem cell colonies were found.  
In contrast, cells grown for 4 days in DKSFM supplemented with BMP4 yielded colonies of 
hiPSCs in between differentiating cells. Furthermore, QPCR analysis of siHIPK4 treated cells 
after 10 days of differentiation detected no increase in K18, even though the HIPK4 knock-
down efficiency reached 30%. Compared to the fully supplemented medium, this condition 
led to much lower levels of K18, in both, siHIPK4 treated and non-targeting siControl treated 
cells.  
Similar results were obtained during the differentiation with DKSFM without any 
supplements. Bright field images showed remaining hiPSC colonies in between 
differentiating cells. Regarding the QPCR analysis, there was no increase in K18 levels after 
10 days in siHIPK4 treated cells compared to the non-targeting control, even though the 
knock-down efficiency reached 59%. Furthermore, the K18 levels remained low (relative 
quantity value of 0.23) in both treatments, compared to cells grown in fully supplemented 
medium.  
Taken together, the effect of HIPK4 knock-down on the expression level of K18 was only 
detectable in the presence of RA, whereas the withdrawal of RA from the initial differentiation 
medium (Differentiation Medium I) diminished the effect. 
Figure 29: Schematic of varying culture conditions during differentiation. Human induced pluripotent stem 
cells (hiPSCs) were seeded for differentiation in four different culture conditions for the first four days, defined 
keratinocyte serum free medium (DKSFM) supplemented with retinoic acid (RA) and BMP4, with just RA, or just 
BMP4, or without both. On day 4 medium was change to DKSFM without supplements. Cells were harvested on 
day 5 and 10.  
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Figure 30: Influence of medium composition on the HIPK4 knock-down effect during differentiation. HIPK4 
was knocked-down in hiPSCs using siRNAs (siHIPK4), and differentiated for 10 days. Control cells were transfected 
with a non-targeting control. Differentiation was induced in four different culture conditions, defined keratinocyte 
serum free medium (DKSFM) with retinoic acid (RA) and bone morphogenetic protein 4 (BMP4) (DKSFM+), with RA 
(DKSFM+RA) or BMP4 ((DKSFM+BMP4) or without both (DKSFM-). Large bright field images were combined from 
36 images. On day 5 (d5) and 10 (d10) cells were harvested and expression levels of HIPK4 and keratin 18 were 
analyzed using QPCR. Normalization to GAPDH. Quantities are relative to siControl in DKSFM+ d10.   
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3.4.5 Influence of HIPK4 overexpression on differentiating cells 
 
As shown before, the knock-down of HIPK4 in hiPSCs and their subsequent differentiation 
into epithelial cells, led to an increase in K18 expression. This finding raised the question, if 
the overexpression of HIPK4 also affects the expression of K18. In order to answer this 
question, hiPSCs were transduced with a lentiviral HIPK4 expression vector and an empty 
lentiviral vector as a control. Differentiation was induced by exposing the cells to 
Differentiation Medium I for 4 days. At day 4 medium was switched to Differentiation Medium 
II until day 10. Cells were harvested on day 5 and on day 10, as in previous experiments, 
and total RNA was isolated. Figure 31 displays the QPCR analysis of this experiment. As 
expected, the HIPK4 level in HIPK4-transduced cells was increased, compared to the control 
or non-treated cells. However, the levels of epithelial markers, including K8, K18, and p63 on 
day5, were not significantly different under control conditions. The expression levels of K8 
and K18 on day 10 were slightly increased for HIPK4 overexpressing cells, but the level of 
p63 was identical for all three conditions.  
In summary, in contrast to the knock-down of HIPK4, the overexpression of HIPK4 
showed no significant effect on the differentiation of hiPSCs into an epithelial lineage. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 31: QPCR analysis of epithelial markers and HIPK4 in HIPK4 overexpressing cells. HiPSCs were 
transduced with a lentiviral HIPK4 expression vector (HIPK4 OE), or with an empty vector (empty vector OE) as 
a control, and differentiated for 10 days. Cells were harvested after 5 (d5) and 10 days (d10) and analyzed for 
their expression of HIPK4, keratin 8, keratin 18, and p63. Values were normalized to GAPDH and 18S. Normal 
human keratinocytes (NHK) served as a reference sample.  
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4 Discussion 
 
4.1 Advantages of using induced pluripotent stem cells 
 
The technology of induced pluripotency offers great possibilities for various fields of 
research and application. It enables the investigation of developmental processes, especially 
in humans, since the generation of human induced pluripotent cells is not burdened with 
ethical concerns, in contrast to research with human embryonic stem cells. Besides studying 
embryonic development in healthy cells, the development of genetic diseases can be 
examined. HiPSCs can be derived from patients with a specific disease or they can be 
genetically modified in order to introduce disease-specific mutations. Subsequent 
differentiation into a cell type of interest would offer the possibility to monitor the 
pathogenesis and to investigate the involved pathways. Furthermore, disease specific 
hiPSCs can be differentiated into affected cell types and serve as an in vitro model for drug 
testing.  
One major goal of iPSC research is to use these cells as a source of healthy cells for 
transplantation, as it is already in process for adult stem cells. To date, haematopoietic stem 
cells are used for the treatment of leukemia patients or patients after chemotherapies. Many 
clinical trials on adult stem cells transplanted into patients are already in process, for 
example for the treatment of spinal trauma (ClinicalTrials.gov identifier: NCT01772810), 
heart failures (ClinicalTrials.gov identifier: NCT01758406), or diabetes mellitus 
(ClinicalTrials.gov identifier: NCT01121029). However, adult stem cells are rare and the 
search for matching donors, in the case of allogeneic transplantations, is complicated. 
Furthermore, the extraction of bone marrow as a source of haematopoietic stem cells is a 
painful process for the patients.  
HiPSCs represent a nearly inexhaustible source of pluripotent cells. They can be 
generated from adult somatic cells of nearly every differentiation lineage. For example, a 
small punch biopsy from the skin is sufficient to obtain fibroblasts, which can be expanded in 
culture, reprogrammed, and differentiated into the cell type of interest. Unfortunately, this 
process is not as trivial as it seems. Before using hiPSCs for transplantations, many open 
questions need to be answered and problems need to be solved.  
A crucial issue concerning the use of hiPSCs for cell replacement therapy is the 
establishment of simple and effective protocols for the differentiation of these pluripotent cells 
towards cell lineages of interest. To date, no published differentiation protocol yielded 100% 
pure populations of differentiated cells (Robinton and Daley, 2012). Methods to enrich cells 
of interest, including fluorescence activated cell sorting, showed to be promising (Doi et al., 
2014). Nevertheless, these methods require high amounts of cells and due to the exhausting 
procedure the cells need to recover afterwards.  
Even though the differentiated cells can be investigated for their expression of cell type 
specific markers and tested for their functionality, they are still artificially generated and it is 
not clear how they behave in a living organism, especially in humans.  
Since the discovery of induced pluripotent stem cells, (Takahashi and Yamanaka, 2006) 
much effort has been put into the investigation and study of these cells and their potential. 
Although many questions have been solved there still remain a lot of unresolved issues 
which need to be addressed. 
In this work hiPSCs were generated by infecting somatic cells with lentiviral vectors 
harboring the four Yamanaka factors. This is a very efficient method for the generation of 
pluripotent cells. Since the focus of this work laid on the differentiation of hiPSCs towards an 
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epidermal fate, the aspect of generating iPSCs without genomic integrations was therefore 
neglected. Nevertheless, genomic instabilities due to the transduction with lentiviral particles 
are possible. Furthermore, the genomic integration of reprogramming factors into the 
genome and the subsequent reprogramming can cause genomic rearrangements and 
epigenetic changes. The cultured hiPSCs used for the experiments described in this thesis 
show no phenotypic changes and remain stably pluripotent in culture. The pluripotent state 
was proved by expression analysis via QPCR, by immunofluorescence stainings, to 
demonstrate the expression of pluripotency associated markers on protein level, and by the 
most stringent test, the teratoma assay.  
 
 
4.2 Differentiation of hiPSCs into epithelial cells and the importance of 
generating efficient protocols 
 
The differentiation of pluripotent cells into any kind of somatic cell is of major interest, 
especially in the field of regenerative medicine in dermatology. Skin replacements for 
patients with large burn injuries could be generated from patient-specific hiPSC-derived 
keratinocytes. 
Establishing reliable and efficient protocols for the differentiation of hiPSCs into 
keratinocytes, the predominant cell type of the epidermis, enables the investigation of 
processes of homeostasis and development of healthy skin as well as the pathogenesis of 
skin diseases. In addition, it allows to investigate the dysregulation during skin development 
which leads to skin diseases.  
Existing protocols (summarized in paragraph “1.3 Differentiation of pluripotent cells into 
keratinocytes in vitro”) have progressively improved the efficiency of generating pluripotent 
cell-derived keratinocytes. Nevertheless, in order to use the generated keratinocytes for skin-
replacements, they need to yield 100% pure populations. Differentiation protocols are usually 
based on processes which take place during the in vivo development. The optimization of 
these protocols require a fundamental knowledge about these processes, which are not 
completely solved to date. 
The focus of this work is on unknown factors, which play a role during the early steps of 
differentiation of pluripotent stem cells into keratinocytes. 
The used differentiation protocol was modified from a published protocol (Itoh et al., 
2011). The modifications comprise the seeding of hiPSCs as single cells, rather than 
culturing them in colonies. Seeding hiPSCs as single cells for the induction of differentiation 
has the effect, that every cell has the same exposure to the differentiation medium. When 
grown in colonies, the tightly packed formation makes it difficult to expose every cell in the 
same way to the differentiation medium, especially the cells in the center of the colony.  
However, hiPSCs as well as hESCs show low clonal expansion potential and easily 
undergo apoptosis under single cell conditions. Therefore, the cells were treated with ROCK-
Inhibitor prior to seeding, to avoid dissociation-induced apoptosis (Watanabe et al., 2007).  
The medium used for the differentiation is a fully supplemented medium without the 
addition of fetal calf/bovine serum. The addition of serum supplements the medium with a 
black box of undefined factors with unknown concentrations (Evans et al., 1956; van der Valk 
et al., 2010). The used serum-free medium ensures comparable, stable culture conditions in 
every experiment.  
According to published protocols, BMP4 and RA were added for the first four days of 
differentiation (described in paragraph “2.2.4 Epithelial differentiation protocol”). 
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At the beginning of differentiation, the cells represent a heterogeneous population, but as 
shown in figure 9, within the heterogeneous population, colonies of keratinocyte-like cells 
occur. During the 30-day differentiation process, keratinocytes are enriched due to the 
medium composition, which favors and promotes keratinocyte growth. The aim of the 
differentiation experiment was to confirm that the generated hiPSCs are able to be directed 
into an epidermal lineage. This was proven by real-time qPCR analysis, genome wide 
expression analysis and immunofluorescence stainings. 
During the first 5-10 days of differentiation, the cells show a decrease in expression of 
pluripotency associated markers (Figure 10A). On the other hand, they show an upregulation 
of K8 and K18 (Figure 10B). The expression of K8 and K18 reaches a peak on day 15 and 
subsequently decreases. K8 and K18 are the first pair of keratins which are expressed during 
the epidermal development in vivo, when the epidermis consists of a single-layered 
epithelium (see paragraph “The embryonic development of the epidermis”). The cells of this 
single-layered primitive ectoderm proliferate and migrate upwards to build suprabasal layers 
and a stratified epithelium. K8 and K18 are then replaced by K5 and K14. These markers are 
characteristic for the cells of the basal layer of a stratified epidermis.  
The downregulation of pluripotency associated markers and the subsequent upregulation 
of K8 and K18 demonstrates the transition of an undifferentiated state towards an epithelial 
fate. Furthermore, the switch in expression from K8 and K18 to K5 and K14 shows the 
maturation of these cells at later time points (~ day 25). 
Genome wide expression analysis of cells differentiated for 10 days, compared to hiPSCs, 
allowed to establish a list of 5741 significantly regulated genes. Subsequent hierarchical 
clustering was performed and presented as a heat map (Figure 12). 
As expected the biological replicates clustered together to build three groups, indicating 
good quality of samples. Interestingly, differentiated cells grouped closer to hiPSCs then to 
NHK, due to the fact that they are in a very early state of differentiation. 
Furthermore, the fold changes of pluripotency-associated genes and keratinocyte 
markers, shown in figure 13, indicate that the differentiated cells show a comparable gene 
expression level to NHK. It is interesting to notice that K8 and K18 are upregulated in 
differentiated cells and not in NHK. This result was expected, since NHKs are differentiated 
and do not express K8 or K18 anymore. 
The performed differentiation experiments could confirm the successful generation of 
keratinocytes from reprogrammed human fibroblasts. The hiPSC-derived keratinocytes 
express markers of basal keratinocytes on RNA and protein level.  
 
 
4.3 High-throughput screens as the method of choice to find single candidates 
involved in the development of keratinocyte precursors 
 
High-throughput and high-content screens are utilized in many research fields. Growing 
drug and gene libraries, as well as advanced automation and computerized analysis, enables 
the application of this method to nearly every questioning, including screening of active 
factors, effective drugs or small compounds. Furthermore, it enables cost-effective, time 
saving experiments in large scales (Boutros and Ahringer, 2008; Desbordes and Studer, 
2013). 
High-throughput can be applied to knock-down experiments, by transfecting cells with a 
library of siRNAs, to small compound screens, in order to investigate the effect of small 
compounds on the cell behavior, or to drug toxicity screens.  
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Drug toxicity screens are inalienable in clinical trials of new therapeutics and are of major 
interest for pharmaceutical industry. To date, these screens are performed with highly 
proliferative immortalized cell lines or cancer cells, since large amounts of cells are needed. 
However, the results obtained with these cells are not always applicable to normal human 
cells. The use of hiPSC-derived differentiated cells in high-throughput drug screens ensures 
an unlimited source of fully differentiated adult human cells (Ebert and Svendsen, 2010).  
In this work, a protocol was established to knock-down specific genes (kinome library of 
about 800 siRNAs) during the differentiation of hiPSCs into early epithelial cells in a high-
throughput procedure. The application of high-throughput screens during differentiation 
opens new possibilities to study developmental processes. Furthermore, it enables to 
generate gene expression patterns for precursor cells in different stages, and to find key 
factors which are characteristic for these stages.  
The establishment of this experiment included preliminary experiments in order to 
determine the right settings.  
As performed in above described differentiation experiments, the seeding of single cells 
instead of cell clumps ensures the same medium exposure for every cell. Therefore, a single 
cell seeding was also performed for the high-throughput experiments. Again, the cells were 
pre-treated with ROCK-inhibitor to prevent single cells induced apoptosis.  
Further, the right cell number had to be determined. Therefore, the cells were seeded in 
different cell numbers. After a culture time of 10 days the cells were stained using an 
antibody against K18 together with a nuclear stain. The cell number and the number of 
positively stained cells were detected with a cell counter software. To ensure the proper 
detection of stained single cells, it has to be taken into account, that the wells should not be 
100% confluent, after 10 days of culture, while reaching a minimum of 1000 cells/well. The 
most promising results were obtained by seeding 4000 cells per well (data not shown), 
whereas higher seeding numbers resulted in confluent wells, and lower seeding numbers 
show poor attachment of the cells.  
Beside the right cell number, the control conditions and the seeding procedure, also the 
right marker for the read out was determined. Most convenient are markers with a nuclear 
expression, because they are easier to detect by the software. Since, however, the proper 
binding of the antibody is more important than the location of the antigen, an efficient and 
specific antibody should always be preferred, even if it detects a cytoplasmic antigen. For the 
differentiation into early epithelial cells, the search for quantitative markers was limited to K8 
and 18, which are cytoplasmic, and p63, which is expressed in the nucleus. Unfortunately, 
stainings with commercially available p63 antibodies did not achieve the desired quality and 
intensity, compared to the results obtained by using K18 antibodies. For this reason, an 
antibody against K18 was used for the final screen readout.  
Another aspect is the duration of culture. The drawback of an experiment in a high-
throughput process is the rather small size of the cavities (0.109 cm2) and the maximum 
volume is 100 µL. Furthermore, changing the medium by the automated workstation should 
be avoided in order to protect the cells from being aspirated. All these points taken into 
account, thus the cells were seeded in 50 µL medium and after 5 days additional 50 µL fresh 
medium were added and the cells cultured until day 10. A culture time longer than 10 days is 
not recommended, due to the aforementioned reasons.  
Trial runs without siRNAs and transfection reagent are necessary, in order to standardize 
the performance, which results in saving costs.  
The high-throughput screen was performed one time in duplicate and one time with a 
single set. The analysis of the screen data includes the plate normalization, where the 
relative signal of each well was compared to the median of the sample wells of the whole 
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plate. The purpose of normalization is to avoid technical discrepancies, including evaporation 
in the edge wells, pipetting errors or medium gradients. The normalized values were then 
transformed into z-scores, which include also the mean and the standard deviation of the 
normalized sample values.  
In knock-down assays, a strong effect is indicated by a negative z-score. From the 
resulting hit list the first fifty candidates were analyzed for their effect on morphological 
changes, colony formation and intensity of the signals. Since screen data were analyzed 
using computerized tools it is needful to verify their “hit” status and compare the obtained 
images by eye. In some cases, the secondary antibody precipitates and leads to unspecific 
signals which result in false positive signals.  
By examining the images of the first fifty hits, the size and amount of keratin fibers as a 
measure of the state of differentiation, was of major interest. Hits with clear positive stainings 
were chosen for further analysis, in order to validate the screen results. 
In a pilot experiment, the chosen candidates were knocked-down in hiPSCs, which were 
subsequently differentiated for 10 days, and analyses were performed using real-time qPCR 
(data not shown). 
However, the K18 expression results obtained upon HIKP4 knock-down were the most 
meaningful, and yielded high K18 expression levels (Figure 17). Regarding the morphology, 
the cells treated with HIPK4 siRNA showed the highest potential to develop into epithelial-like 
colonies. Due to these pilot results, HIPK4 was chosen as the candidate of interest for further 
analysis, even though the knock-down of HIPK4 did not result in the lowest z-score. 
High-throughput experiments are great methods to screen large amounts of factors, 
compounds or genes, in a cost-effective and timesaving process. Even though the screen 
data need to be validated by additional experiments, it is a method-of-choice to obtain a 
general direction and first indications.  
In addition to the performed high-throughput differentiation experiment, also precursor 
cells could be used for the screens. Therefore, cells could be pre-differentiated for 10 days 
and then be used for following 10 days of differentiation in a high-throughput process. This 
would enable to characterize precursors and identify markers for different stages.  
 
 
4.4 The role of HIPK4 during the differentiation of human induced pluripotent 
stem cells into epithelial precursors 
 
HIPK4 is the last described member of the homeodomain-protein kinase family of 
serine/threonine kinases. They all harbor a highly conserved serine/threonine catalytic 
domain at their N-terminus (He et al., 2010). While HIPK1, 2 and 3 are localized in nuclear 
speckles in the nucleus, HIPK4 demonstrates a rather cytoplasmic localization, which is 
supported by the fact that it does not have a nuclear localization signal (NLS) (Arai et al., 
2007). HIPK2 was shown to phosphorylate p53 at Ser49 after UV irradiation (D’Orazi et al., 
2002), and ∆Np63α upon treatment with genotoxic agents (Lazzari et al., 2011). Similar to 
HIPK2, HIPK4 was shown to phosphorylate p53 at serine 9 (Arai et al., 2007). Further 
functions of HIPK4 are not yet known and it is unclear if ∆Np63α is also phosphorylated by 
this kinase. 
As described in the introduction (see paragraph “1.1.2.1 P63”), p63 is a very important 
regulator of epithelial development. Especially during the early phase of differentiation the 
∆Np63α isoform plays a pivotal role (Guerrini et al., 2011). Interestingly, p63 is known to be 
phosphorylated, and thus degraded at later phases, when cells are postmitotic and in a 
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process of terminal differentiation. One could speculate that HIPK4 phosphorylates p63, 
which then results in the degradation of p63 and enhanced differentiation towards the 
epithelial lineage. Further experiments are necessary to test this hypothesis. 
During 30 days of differentiation, the expression pattern of HIPK4 (Figure 18) mimics the 
one of K8/K18 (Figure 10B). This led to the assumption, that HIPK4 might play a role during 
the early stages of keratinocyte differentiation when K8 and K18 are expressed.  
It could be clearly demonstrated, that the knock-down of HIPK4 significantly affects the 
expression levels of K8 and K18, as well as K5 and K14 (Figure 21). However, as shown in 
figure 28, this effect is due to the inhibition of HIPK4 during the first 5 days of differentiation. 
The results demonstrate, that a persistent knock-down for 10 days did not enhance the 
expression of epithelial markers. During these first days the pluripotent cells undergo a 
determination towards an epidermal lineage and the results obtained by the performed 
experiments indicate, that HIPK4 exerts its effect during this phase. 
The supplementation of the differentiation medium with BMP4 and RA was shown to 
promote the differentiation process significantly. BMP4 was shown to enhance epidermal 
specification (Archer et al., 2011), and RA induces the expression of p63 (Metallo et al., 
2008). In order to determine if the effect of HIPK4 correlates with the action of BMP4 and/or 
RA, they were withdrawn from the medium (Figure 30).The withdrawal of BMP4 could not 
diminish the effect of HIPK4 knock-down on K18 expression, even though the overall K18 
expression levels were lower in both siHIPK4 treated cells and in the control. Interestingly, in 
control treated cells, K18 levels did not increase from day 5 to day 10, whereas siHIPK4 
transfected cells show an increase. As already mentioned, BMP4 promotes the differentiation 
into an epidermal lineage. Without BMP4, the enhancing effect is diminished in control 
conditions, but upon HIPK4 knock-down, the levels of K18 increase from day 5 to day 10. 
This lead to the suggestion, that in the absence of BMP4 during epithelial differentiation, the 
knock-down of HIPK4 rescues the increasing expression levels of K18. Nevertheless, this 
only holds true in the presence of RA.  
In contrast, upon withdrawal of RA, no HIPK4 knock-down induced increase of K18 is 
detectable. Also in this condition, the overall K18 expression is lower than under culture 
condition in the presence of both BMP4 and RA. Interestingly, upon withdrawal of RA, the 
effect of HIPK4 knock-down on the expression of K18 is abolished. Under these conditions, 
HIPK4 siRNA treated cells demonstrate even lower K18 levels compared to the control 
treatment. Also under withdrawal of both BMP4 and RA there is no detectable increase in 
K18 under HIPK4 knock-down.  
These results show, that the HIPK4 knock-down effect on K18 is strongly RA dependent, 
and no increase of K18 under HIPK4 knock-down is detected upon withdrawal of RA. 
Furthermore, these results lead to the assumption, that in the presence of RA but under 
withdrawal of BMP4, the knock-down of HIPK4 can either enhance the RA pathway or 
rescue the function of BMP4.  
It is known that during in vitro differentiation of pluripotent cells into an epidermal lineage, 
the addition of RA and BMP4 results in the enhanced expression of K18 and p63. While 
BMP4 actively blocks neural fate and induces apoptosis in neural precursors, RA leads to the 
induction of p63. It is not yet resolved how RA induces p63, since there is no RA responsive 
element in the p63-promoter (Metallo et al., 2008). Further, it is known that during 
differentiation, the phosphorylation of p63 and thus its degradation marks the transition of 
basal to suprabasal cells. To date, it is not clear, which kinase induces p63 degradation by 
phosphorylating it (Suzuki and Senoo, 2012). 
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The results obtained in this work clearly demonstrate a role of HIPK4 during the early 
steps of epithelial differentiation. It is not clear how HIPK4 acts, but it has a regulating role on 
the K8/K18 expression.  
The investigations in this work show that the overexpression of HIPK4 did not result in 
decreased levels of epithelial markers. The absence of a detectable effect after HIPK4 
overexpression lead to the suggestion, that the endogenous level of HIPK4 could be 
sufficient to phosphorylate p63, thus a higher HIPK4 level would not increase the level of 
phosphorylated p63. During development, the phosphorylation of p63 results in its 
degradation, and thus reduced p63 levels would be expected after HIPK4 overexpression. 
On the other hand, the investigation of the expression levels of epithelial markers was 
performed after 10 days; this period could be too short for a final prediction about the 
influence of HIPK4 overexpression on p63. It would be of great help to analyze the 
phosphorylation status of p63 after HIPK4 overexpression, as well as after the knock-down.   
Further experiments need to answer the question, if HIPK4 phosphorylates p63 and 
thereby leads to the degradation of p63 and the subsequent differentiation of epithelial 
precursors into keratinocytes, as it is the case during the development. In this case, the early 
knock-down of HIPK4 would reduce the phosphorylation of p63, resulting in higher p63 levels 
(which was shown in figure28), and lead to an increase of epithelial precursors. The 
dependency of HIPK4 on RA might be due to the induction of p63 by RA.  
Further investigations are needed to determine the role of HIPK4. For example, HIPK4 
and a kinase-deficient mutant form could be overexpressed in cells, which do not express 
HIPK4 at all. The subsequent analysis of the phosphorylation status of p63 by specific 
phospho-p63 antibodies would help to investigate if p63 is phosphorylated. Co-
immunoprecipitation could also determine the interaction of HIPK4 and p63, by pulling down 
HIPK4 and detecting the presence of p63 in the received fraction by western blot.  
In addition, the differentiation time could be prolonged up to 30 days, in order to 
investigate, if the early knock-down of HIPK4 still has an influence at later differentiation 
stages. 
It would also be of interest, to perform differentiation experiments without siRNA 
transfection, but instead using kinase inhibitors, to block HIPK4 kinase activity. If blocking of 
HIPK4 kinase activity results in increased expression of epithelial markers, this would 
indicate that it is in fact the kinase activity, which negatively regulates the epithelial 
development.  
Unfortunately, HIPK4 is a relatively unknown kinase, and to date there is no specific 
inhibitor known, which only inhibits HIPK4 or HIPKs. Therefore, it would be more specific to 
perform gene targeting using zink-finger nucleases, which induce site-specific deletions in 
the kinase domain through homologous recombination. This would enable to investigate the 
kinase activity of HIPK4. 
This work demonstrates for the first time that the kinase HIPK4 is involved in the process 
of epithelial differentiation. On this basis, it will be possible to investigate the function of 
HIPK4 in more detail and eventually exploit the gained knowledge in order to establish novel 
and more effective protocols for the differentiation of human pluripotent stem cells towards 
the epithelial lineage. Improving the efficiency of differentiation protocols is necessary in 
order to use iPS-derived cells for therapeutically purpose.  
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